amiodarone has been researched along with Postoperative Complications in 243 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Postoperative Complications: Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this double-blind, placebo-controlled trial, patients at high risk of postoperative atrial fibrillation scheduled to undergo major thoracic surgery were randomized to N-acetylcysteine plus amiodarone or placebo plus amiodarone." | 9.51 | Amiodarone with or without N-Acetylcysteine for the Prevention of Atrial Fibrillation after Thoracic Surgery: A Double-blind, Randomized Trial. ( Amar, D; Chung, MK; Desiderio, D; Fischer, GW; Isbell, JM; Jones, DR; Meyers, BF; Milne, GL; Molena, D; Park, BJ; Pedoto, A; Roistacher, N; Rusch, VW; Tan, KS; Zhang, H, 2022) |
| "The aim of this study was to compare the effects of prophylactic dronedarone and amiodarone in prevention of arrhythmias during and following off-pump coronary artery bypass grafting (OPCAB)." | 9.24 | Prophylactic amiodarone vs dronedarone for prevention of perioperative arrhythmias in offpump coronary artery bypass grafting: A pilot randomized controlled trial. ( Goswami, A; Sen, C; Som, A, 2017) |
| "Prophylactic topical application of amiodarone may be effective and safe for preventing post-operative new-onset atrial fibrillation." | 9.22 | Effectiveness of intra-operative topical amiodarone for prevention of postcardiac surgery new-onset atrial fibrillation: A review of current evidence. ( Baranchuk, A; Chen, X; El-Diasty, M; Fernandez, AL; Ross-White, A; Sartor, C; Zhang, S, 2022) |
| "This study examined the influence of preoperative administration of amiodarone and metoprolol in preventing postoperative atrial fibrillation (AF) after coronary artery bypass grafting (CABG) surgery." | 9.20 | Is the Preoperative Administration of Amiodarone or Metoprolol More Effective in Reducing Atrial Fibrillation: After Coronary Bypass Surgery? ( Erkut, B; Onk, OA, 2015) |
| "Our aim was to estimate the costs and health benefits of routinely administered postoperative amiodarone as a prophylactic agent in reducing the risk of atrial fibrillation in patients undergoing surgery for lung cancer." | 9.19 | Amiodarone is a cost-neutral way of preventing atrial fibrillation after surgery for lung cancer. ( Christensen, TD; Pilegaard, HK; Riber, LP, 2014) |
| "The patients in the amiodarone prophylaxis group had a reduction in the risk of atrial fibrillation of 23% (12 to 31); number needed to treat was 4." | 9.16 | Amiodarone significantly decreases atrial fibrillation in patients undergoing surgery for lung cancer. ( Christensen, TD; Hoejsgaard, A; Jensen, HK; Pilegaard, HK; Riber, LP, 2012) |
| " Overall atrial fibrillation occurred more frequently in the perioperative intravenous amiodarone group compared with the placebo group (59." | 9.14 | Perioperative intravenous amiodarone does not reduce the burden of atrial fibrillation in patients undergoing cardiac valvular surgery. ( Beaulieu, Y; Carrier, M; Couture, P; Denault, AY; Lambert, J; Levesque, S; O'Meara, E; Pagé, P; Roy, D; Talajic, M; Tardif, JC, 2010) |
| "In the AFIST III (Atrial Fibrillation Suppressions Trial III), anterior fat pad (AFP) retention did not decrease the incidence of postoperative atrial fibrillation (POAF), but prophylaxis with amiodarone did." | 9.13 | Impact of amiodarone on the ability of anterior fat pad retention to prevent postcoronary arterial bypass grafting atrial fibrillation incidence: a substudy of the AFIST III (Atrial Fibrillation Suppression Trial III). ( Coleman, CI; Dale, K; Gallagher, R; Henyan, N; Kluger, J; Reinhart, K; Sander, S; White, CM, 2008) |
| "The purpose of this study was to estimate the costs and health benefits of routinely administered postoperative amiodarone as prevention of atrial fibrillation for patients undergoing coronary artery bypass grafting (CABG) for stable angina." | 9.13 | Amiodarone cost effectiveness in preventing atrial fibrillation after coronary artery bypass graft surgery. ( Christensen, TD; Hjortdal, VE; Kristiansen, IS; Zebis, LR, 2008) |
| "The patients in amiodarone prophylaxis experienced a reduction in risk of atrial fibrillation of 14% (95% confidence interval [CI], 5." | 9.12 | Practical regimen for amiodarone use in preventing postoperative atrial fibrillation. ( Christensen, TD; Folkersen, L; Hjortdal, VE; Mikkelsen, MM; Sørensen, HT; Thomsen, HF; Zebis, LR, 2007) |
| "Postoperative intravenous amiodarone prophylaxis followed by oral amiodarone significantly reduces the incidence of atrial fibrillation after off-pump coronary artery bypass grafting and the ventricular rate during atrial fibrillation." | 9.12 | Intravenous and oral amiodarone for the prevention of postoperative atrial fibrillation in patients undergoing off-pump coronary artery bypass surgery. ( Ata, Y; Ozkan, H; Ozyazicioglu, A; Turk, T; Vural, H; Yavuz, S, 2007) |
| "To compare the cost-effectiveness of intravenous plus oral amiodarone, atrial septal pacing, and both strategies combined to prevent atrial fibrillation after open heart surgery." | 9.11 | Economic analysis of intravenous plus oral amiodarone, atrial septal pacing, and both strategies to prevent atrial fibrillation after open heart surgery. ( Caron, MF; Coleman, CI; Horowitz, S; Kalus, JS; Karapanos, A; Kluger, J; Reddy, P; White, CM, 2004) |
| "We studied the use of perioperative IV and oral administration of amiodarone for the prevention of postoperative atrial fibrillation in patients undergoing coronary artery bypass graft surgery (CABG)." | 9.11 | Giving IV and oral amiodarone perioperatively for the prevention of postoperative atrial fibrillation in patients undergoing coronary artery bypass surgery: the GAP study. ( Hollander, G; Kerstein, J; Lichstein, E; Majid, M; Qamar, M; Shani, J; Soodan, A, 2004) |
| "This prospective, randomized, double-blind, placebo-controlled study compared the efficacy and safety of amiodarone and sotalol in the prevention of atrial fibrillation (AF) following open heart surgery." | 9.11 | Amiodarone versus sotalol for the treatment of atrial fibrillation after open heart surgery: the Reduction in Postoperative Cardiovascular Arrhythmic Events (REDUCE) trial. ( Arcidi, JM; Hilleman, DE; Lenz, TL; Mohiuddin, SM; Mooss, AN; Packard, KA; Rovang, KS; Sugimoto, JT; Wurdeman, RL, 2004) |
| "This study was designed to assess the effects of a perioperative dosing regimen of amiodarone administration, high thoracic epidural anesthesia (TEA), or a combination of the 2 regimens on atrial fibrillation (AF) after coronary artery bypass grafting (CABG)." | 9.11 | Effects of amiodarone and thoracic epidural analgesia on atrial fibrillation after coronary artery bypass grafting. ( Aldershvile, J; Eliasen, K; Hviid, LB; Krogsgaard, K; Nygård, E; Pedersen, FM; Ravn, J; Svendsen, JH; Sørensen, LH; Thomassen, L, 2004) |
| "To assess the prophylactic effect of postoperative oral amiodarone on the incidence and severity of atrial fibrillation (AF) after coronary artery surgery." | 9.10 | Postoperative oral amiodarone as prophylaxis against atrial fibrillation after coronary artery surgery. ( Haddad, F; Hayek, G; Madi-Jebara, S; Rahbani, P; Yazigi, A; Zeid, HA, 2002) |
| "The purpose of this study was to evaluate the safety and efficacy of postoperative administration of prophylactic amiodarone in the prevention of new-onset postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting." | 9.10 | Amiodarone reduces the incidence of atrial fibrillation after coronary artery bypass grafting. ( Apaydin, A; Atay, Y; Ayik, F; Buket, S; Calkavur, T; Islamoglu, F; Nalbantgil, S; Posacioglu, H; Yagdi, T, 2003) |
| "This pilot study aimed to compare right atrial pacing, intravenous amiodarone and oral beta-blockers in the prevention, time to onset, duration and effect on hospital stay of postoperative atrial fibrillation (AF) after coronary artery bypass graft surgery (CABG) at our center." | 9.10 | Effect of right atrial pacing, intravenous amiodarone and beta blockers for suppression of atrial fibrillation after coronary artery bypass surgery: a pilot study. ( Cardona, F; Cox, RA; Pérez, CM; Seide, H, 2003) |
| "This prospective randomized study aims at evaluation and comparison of the prophylactic effects of amiodarone versus digoxin and metoprolol combination in postcoronary bypass atrial fibrillation." | 9.10 | Amiodarone versus digoxin and metoprolol combination for the prevention of postcoronary bypass atrial fibrillation. ( Catav, Z; Gunaydin, S; Kandemir, O; Tokmakoglu, H; Yorgancioglu, C; Zorlutuna, Y, 2002) |
| "Intraoperative prophylactic use of amiodarone does not prevent new onset of atrial fibrillation in patients undergoing coronary artery bypass grafting and had no effect on outcome." | 9.09 | Intraoperative amiodarone as prophylaxis against atrial fibrillation after coronary operations. ( Dörge, H; Messmer, BJ; Schoberer, M; Schoendube, FA; Stellbrink, C; Voss, M, 2000) |
| "Atrial fibrillation occurred in 9 (12%) of the amiodarone group patients and in 26 (34%) of the control group patients during hospitalization (p < 0." | 9.09 | Intravenous amiodarone for prevention of atrial fibrillation after coronary artery bypass grafting. ( Chang, CM; Chen, SA; Cheng, JJ; Hung, CR; Lee, RJ; Lee, SH; Lu, MJ, 2000) |
| "Our aims were to examine whether the administration of amiodarone or magnesium sulphate after coronary artery bypass graft surgery (CABG) could reduce the occurrence of atrial fibrillation, and to identify the risk factors associated with atrial fibrillation after CABG." | 9.09 | Intravenous amiodarone or magnesium sulphate is not cost-beneficial prophylaxis for atrial fibrillation after coronary artery bypass surgery. ( Adamec, R; Perneger, TV; Romand, JA; Suter, PM; Treggiari-Venzi, MM; Waeber, JL, 2000) |
| "Of the 100 patients recruited for the Amiodarone arm of the study, 12 were excluded for a variety of reasons detailed in the discussion with atrial fibrillation occurring in 28 (a rate of 32%)." | 9.09 | Effect of amiodarone on atrial fibrillation after coronary artery bypass surgery. ( Harahsheh, BS; Sawalha, WA, 2001) |
| "Both amiodarone and beta-blockers have been shown to decrease the incidence of atrial fibrillation after cardiovascular surgery." | 9.09 | Amiodarone versus a beta-blocker to prevent atrial fibrillation after cardiovascular surgery. ( Greenberg, MD; Katz, NM; Kilborn, MJ; Solomon, AJ, 2001) |
| "The safety and efficacy of amiodarone and propafenone in converting atrial fibrillation or flutter after cardiac surgery were compared in a randomized double-blind trial." | 9.08 | Intravenous amiodarone vs propafenone for atrial fibrillation and flutter after cardiac operation. ( Cappiello, E; Di Biasi, P; Mangini, A; Paje, A; Santoli, C; Scrofani, R, 1995) |
| "Atrial fibrillation occurred in 15% of the patients receiving placebo and in 8% of the patients receiving verapamil (difference not significant)." | 9.08 | Verapamil as prophylactic treatment for atrial fibrillation after lung operations. ( Demedts, M; Demuynck, K; Deneffe, G; Lacquet, L; Tits, G; Tjandra-Maga, T; Van Mieghem, W, 1996) |
| "Postoperative atrial fibrillation occurred in 16 of the 64 patients in the amiodarone group (25 percent) and 32 of the 60 patients in the placebo group (53 percent) (P=0." | 9.08 | Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. ( Bitar, C; Bolling, SF; Daoud, EG; Deeb, GM; Goyal, R; Man, KC; Meissner, MD; Morady, F; Pagani, FD; Strickberger, SA, 1997) |
| "The incidence of clinically significant tachycardia was reduced by amiodarone." | 9.07 | Amiodarone prophylaxis for tachycardias after coronary artery surgery: a randomised, double blind, placebo controlled trial. ( Butler, J; Harriss, DR; Sinclair, M; Westaby, S, 1993) |
| " The question addressed was whether the administration of amiodarone is safe in patients undergoing lung resection either for prophylaxis or treatment of de novo postoperative atrial fibrillation (POAF)." | 8.95 | In patients undergoing lung resection is it safe to administer amiodarone either as prophylaxis or treatment of atrial fibrillation? ( Billè, A; Harling, L; Kolokotroni, SM; Toufektzian, L, 2017) |
| "Despite probably being the most effective prophylactic drug for postoperative atrial fibrillation (POAF), amiodarone is reserved as a second-line agent because of its potential systemic side effects." | 8.93 | Intrapericardial Amiodarone for the Prevention of Postoperative Atrial Fibrillation. ( Chu, FV; Habbab, LM, 2016) |
| "Current guidelines recommend beta-blocker as the first-line preventive treatment of atrial fibrillation (AF) after cardiac surgery; if beta-blocker therapy is contraindicated, then amiodarone is recommended." | 8.88 | Meta-analysis of amiodarone versus β-blocker as a prophylactic therapy against atrial fibrillation following cardiac surgery. ( Gao, D; Gao, Y; Lu, Y; Wang, C; Zhang, C; Zhang, Y; Zhu, J, 2012) |
| "To investigate a possible dose-response relationship between amiodarone and reduction in incidence of postoperative atrial fibrillation, and to determine whether pre- or postoperative initiation of amiodarone is superior." | 8.84 | Amiodarone prophylaxis for atrial fibrillation after cardiac surgery: meta-analysis of dose response and timing of initiation. ( Buckley, MS; Copeland, JG; Hilleman, DE; Nolan, PE; Slack, MK; Tisdale, JE, 2007) |
| "A meta-analysis was conducted to assess the safety of amiodarone in the prevention of postoperative atrial fibrillation." | 8.83 | Safety of amiodarone in the prevention of postoperative atrial fibrillation: a meta-analysis. ( Coleman, CI; Gillespie, EL; Kluger, J; Patel, AA; White, CM, 2006) |
| "The association between amiodarone treatment for postoperative atrial fibrillation (POAF) after surgical aortic valve replacement (SAVR) and both the return to normal sinus rhythm (NSR) and anticoagulation use at discharge has not been extensively studied." | 8.31 | Postoperative Atrial Fibrillation After Surgical Aortic Valve Replacement: Amiodarone and Warfarin Use. ( Beaulieu-Jones, BR; Haime, M; Lin, B; Phillips, AM; Quin, JA, 2023) |
| "The authors assessed the efficacy and safety of landiolol, an ultra-short-acting beta-blocker, with those of amiodarone in the restoration of sinus rhythm for postoperative atrial fibrillation (POAF) in intensive care unit (ICU) patients." | 7.83 | Efficacy and Safety of Landiolol Compared to Amiodarone for the Management of Postoperative Atrial Fibrillation in Intensive Care Patients. ( Fujino, Y; Ohta, N; Shibata, SC; Uchiyama, A, 2016) |
| "The aim of this study was to investigate the effects of long-term use of amiodarone before HTX on early post-transplant atrial fibrillation (AF) and mortality after HTX." | 7.83 | Long-term use of amiodarone before heart transplantation significantly reduces early post-transplant atrial fibrillation and is not associated with increased mortality after heart transplantation. ( Akhavanpoor, M; Bruckner, T; Darche, FF; Doesch, AO; Ehlermann, P; Erbel, C; Frankenstein, L; Gleissner, CA; Helmschrott, M; Katus, HA; Rivinius, R; Ruhparwar, A; Schmack, B; Schweizer, PA; Thomas, D, 2016) |
| "We prospectively collected cases of amiodarone-associated thyrotoxicosis requiring thyroidectomy due to failure of antithyroid treatment, despite amiodarone discontinuation." | 7.78 | Total thyroidectomy for amiodarone-associated thyrotoxicosis: should surgery always be delayed for pre-operative medical preparation? ( Duverger, V; Merat, S; Perrier, E; Pierret, C; Pons, Y; Tourtier, JP, 2012) |
| "Patients with amiodarone-induced thyrotoxicosis (AIT) and left ventricular (LV) systolic dysfunction have a high mortality rate." | 7.78 | Total thyroidectomy in patients with amiodarone-induced thyrotoxicosis and severe left ventricular systolic dysfunction. ( Bartalena, L; Bogazzi, F; De Napoli, L; Marchello, A; Mariotti, R; Martino, E; Materazzi, G; Miccoli, P; Moretti, M; Rossi, G; Tomisti, L, 2012) |
| " After administration of atorvastatin, amiodarone, and fluconazole, rhabdomyolysis developed with electrolyte disturbances (hyperphosphatemia, hyopcalcemia) and a massive increase in creatine kinase and myoglobin." | 7.77 | [Rhabdomyolysis associated with atorvastatin combined with amiodarone and fluconazole]. ( Bruggisser, M; Franz, CC; Krähenbühl, S; Rätz Bravo, AE, 2011) |
| "We investigated the effect of amiodarone on prevention of post-operative atrial fibrillation (POAF) after cardiac surgery." | 7.77 | [Prophylactic use of amiodarone against postoperative atrial fibrillation after cardiac surgery]. ( Araki, E; Osawa, H; Sakurada, T; Sasaki, J, 2011) |
| "Amiodarone is widely used in Europe and the United States for refractory ventricular fibrillation (VF) in various situations, such as VF after myocardial infarction or out-of-hospital cardiac arrest." | 7.76 | [Successful use of intravenous amiodarone for refractory ventricular fibrillation just after releasing aortic cross-clamp]. ( Iwasaki, T; Kanazawa, T; Matsuoka, M; Morimatsu, H; Morita, K; Shimizu, K; Suemori, T; Suzuki, S; Toda, Y; Yokoi, N, 2010) |
| "In a 10-year prospective observational study, 71 of 2651 patients (2885 procedures, 2106 bypass procedures) received amiodarone for newly detected postoperative atrial (n = 70) or ventricular (n = 7) tachyarrhythmia: early treatment (initiation within 60 minutes of arrhythmia detection) and late treatment (after that)." | 7.74 | Impact of early and standardized treatment with amiodarone on therapeutic success and outcome in pediatric patients with postoperative tachyarrhythmia. ( Camphausen, CK; Haas, NA, 2008) |
| "To assess if prophylaxis with moderate doses of amiodarone in the postoperative period of cardiac surgery (coronary artery bypass grafting and/or valve surgery), reduces the incidence of atrial fibrillation in patients with high risk for developing this arrhythmia." | 7.74 | Prevention of atrial fibrillation with moderate doses of amiodarone in the postoperative period of cardiac surgery is safe and effective in patients with high risk for developing this arrhythmia. ( Alves, RJ; Brito, Gd; Geovanini, GR; Glauser, VA; Miguel, GA; Nakiri, K, 2007) |
| "To evaluate the effect of prophylactic amiodarone on length of stay (LOS), postoperative stroke, and postoperative atrial fibrillation (POAF)." | 7.73 | Impact of prophylactic amiodarone on length of hospital stay, stroke, and atrial fibrillation after cardiothoracic surgery. ( Coleman, CI; Gillespie, EL; Ismaili, A; Kardas, M; Kluger, J; Perkerson, KA; Takata, H; White, CM, 2005) |
| "Amiodarone can induce severe hyperthyroidism that justifies its withdrawal and initiation of antithyroid drugs." | 7.72 | [Anaesthesia and amiodarone-associated hyperthyroidism]. ( Bonnevie, L; Lambert, E; Lenoir, B; Mérat, S; Pats, B; Perrier, E, 2004) |
| "This study evaluated the cost-effectiveness of administering prophylactic intravenous (IV) amiodarone therapy to patients undergoing cardiac surgery according to their predicted risk of postoperative atrial fibrillation." | 7.71 | Cost-effectiveness of targeting patients undergoing cardiac surgery for therapy with intravenous amiodarone to prevent atrial fibrillation. ( Mahoney, EM; Thompson, TD; Veledar, E; Weintraub, WS; Williams, J, 2002) |
| "A patient with mechanical heart valves developed bleeding, after the introduction of amiodarone and azithromycin." | 7.70 | Bleeding complication during coumarin therapy due to amiodarone and azithromycin. ( Bharat, V; Mohanty, B, 2000) |
| "To report our experience using high dose oral amiodarone (1,800 mg/day) for the reversion of atrial fibrillation to sinus rhythm in patients submitted to cardiac surgery." | 7.69 | [Use of high-dose oral amiodarone for the reversion of atrial fibrillation during the postoperative period of cardiac surgery]. ( Bodanese, LC; Brauner, FB; Brunini, TM; Guaragna, JC; Linhatti, JL; Martins, V; Pires, RC, 1997) |
| "Amiodarone-induced thyrotoxicosis (AIT) is a rare disorder that is frequently refractory to conventional pharmacologic therapy." | 7.68 | Amiodarone-induced thyrotoxicosis: clinical presentation and expanded indications for thyroidectomy. ( Esselstyn, CB; Kinney, W; McHenry, CR; Mulligan, DC, 1993) |
| "Directed surgical intervention in patients with ventricular tachyarrhythmias who have experienced failure of amiodarone therapy is a common clinical scenario." | 7.68 | Amiodarone-related postoperative adult respiratory distress syndrome. ( Greenspon, AJ; Hurley, W; Kidwell, GA; Mannion, J, 1991) |
| "Iodine-induced hyperthyroidism has been frequently described when iodine is introduced into an iodine-deficient area." | 7.67 | Five patients with iodine-induced hyperthyroidism. ( Braverman, LE; Mordes, JP; Rajatanavin, R; Safran, M; Stoller, WA, 1984) |
| "Treatment with bisoprolol resulted in a trend to lower ventricular response rate in AF cases." | 6.74 | Postoperative oral amiodarone versus oral bisoprolol as prophylaxis against atrial fibrillation after coronary artery bypass graft surgery: a prospective randomized trial. ( Ashoush, R; El Rassi, I; Haddad, F; Hayeck, G; Jebara, V; Madi-Jebara, S; Sleilaty, G; Yazigi, A, 2009) |
| "Amiodarone is a drug frequently used for cardioversion." | 6.73 | Does stopping amiodarone after successfully treating atrial fibrillation occurring after cardiac surgery increase the risk of recurrence? ( Attaran, S; Desai, J; El-Gamel, A; John, L; Sherwood, R, 2008) |
| "Amiodarone was given as 600 mg oral single dose one day before and from days 2 through 7 after surgery." | 6.72 | Amiodarone prophylaxis for atrial fibrillation of high-risk patients after coronary bypass grafting: a prospective, double-blinded, placebo-controlled, randomized study. ( Budeus, M; Erbel, R; Feindt, P; Felix, O; Gams, E; Hennersdorf, M; Lehmann, N; Perings, C; Perings, S; Reimert, K; Röhlen, S; Sack, S; Schnitzler, S; Wieneke, H, 2006) |
| "Amiodarone treated patients had a lower incidence of AF (22." | 6.71 | Amiodarone prevents symptomatic atrial fibrillation and reduces the risk of cerebrovascular accidents and ventricular tachycardia after open heart surgery: results of the Atrial Fibrillation Suppression Trial (AFIST). ( Kluger, J; White, CM, 2003) |
| "Amiodarone plays a pivotal role in the treatment of ventricular and supraventricular arrhythmias." | 6.50 | [Total thyroidectomy in patients with amiodarone-induced hyperthyroidism: when does the risk of conservative treatment exceed the risk of surgery?]. ( Greutmann, M; Huber, GF; Meerwein, C; Schmid, C; Vital, D, 2014) |
| " Inconsistent prescribing practices, variable dosage regimens, and a lack of consensus regarding the appropriate use of amiodarone prompted the need for developing practice guidelines." | 6.44 | Amiodarone for atrial fibrillation following cardiac surgery: development of clinical practice guidelines at a university hospital. ( Khanderia, U; Prager, R; Wagner, D; Walker, PC; Woodcock, B, 2008) |
| "Amiodarone and early CVN was more effective than nonamiodarone therapies with regard to restoring NSR for patients in whom AF developed after elective CABG." | 6.43 | Selective use of amiodarone and early cardioversion for postoperative atrial fibrillation. ( Holmes, EC; Samuels, FL; Samuels, LE, 2005) |
| "Both amiodarone and sotalol were more effective than placebo treatment in reducing the incidence of postoperative AFF." | 6.41 | Amiodarone vs. sotalol as prophylaxis against atrial fibrillation/flutter after heart surgery: a meta-analysis. ( Lenz, TL; Mohiuddin, SM; Mooss, AN; Wurdeman, RL, 2002) |
| "In this double-blind, placebo-controlled trial, patients at high risk of postoperative atrial fibrillation scheduled to undergo major thoracic surgery were randomized to N-acetylcysteine plus amiodarone or placebo plus amiodarone." | 5.51 | Amiodarone with or without N-Acetylcysteine for the Prevention of Atrial Fibrillation after Thoracic Surgery: A Double-blind, Randomized Trial. ( Amar, D; Chung, MK; Desiderio, D; Fischer, GW; Isbell, JM; Jones, DR; Meyers, BF; Milne, GL; Molena, D; Park, BJ; Pedoto, A; Roistacher, N; Rusch, VW; Tan, KS; Zhang, H, 2022) |
| "The incidence of junctional ectopic tachycardia was 37% in the control group and 10% in the amiodarone group." | 5.38 | Prophylactic amiodarone reduces junctional ectopic tachycardia after tetralogy of Fallot repair. ( Dossey, AM; Garcia, X; Imamura, M; Jaquiss, RD; Shinkawa, T, 2012) |
| "When landiolol was administered, enough attention should be paid to the patients whose left ventricular function was low." | 5.36 | [Clinical analysis of precaution against atrial fibrillation following cardiac surgery: landiolol or amiodarone?]. ( Abe, T; Fukuda, T; Haruna, T; Inoko, M; Ito, H; Miyamoto, S; Nakane, E; Nohara, R; Sasaki, K; Uehara, K; Ueyama, K, 2010) |
| "Amiodarone was administered in five patients with life-threatening ventricular arrhythmias resistant to other antiarrhythmic agents: Suppression was obtained in one of two patients with recurrent ventricular tachycardias and control was achieved in three patients with repetitive ventricular tachycardia and ventricular fibrillation, allowing the effective use of intra-aortic balloon counterpulsation (IABP) needed for hemodynamic support." | 5.26 | Intravenous amiodarone in the treatment of various arrhythmias following cardiac operations. ( Charles, S; Gadisseux, P; Installe, E; Schoevaerdts, JC; Tremouroux, J, 1981) |
| "The aim of this study was to compare the effects of prophylactic dronedarone and amiodarone in prevention of arrhythmias during and following off-pump coronary artery bypass grafting (OPCAB)." | 5.24 | Prophylactic amiodarone vs dronedarone for prevention of perioperative arrhythmias in offpump coronary artery bypass grafting: A pilot randomized controlled trial. ( Goswami, A; Sen, C; Som, A, 2017) |
| "Prophylactic topical application of amiodarone may be effective and safe for preventing post-operative new-onset atrial fibrillation." | 5.22 | Effectiveness of intra-operative topical amiodarone for prevention of postcardiac surgery new-onset atrial fibrillation: A review of current evidence. ( Baranchuk, A; Chen, X; El-Diasty, M; Fernandez, AL; Ross-White, A; Sartor, C; Zhang, S, 2022) |
| "This study examined the influence of preoperative administration of amiodarone and metoprolol in preventing postoperative atrial fibrillation (AF) after coronary artery bypass grafting (CABG) surgery." | 5.20 | Is the Preoperative Administration of Amiodarone or Metoprolol More Effective in Reducing Atrial Fibrillation: After Coronary Bypass Surgery? ( Erkut, B; Onk, OA, 2015) |
| "Our aim was to estimate the costs and health benefits of routinely administered postoperative amiodarone as a prophylactic agent in reducing the risk of atrial fibrillation in patients undergoing surgery for lung cancer." | 5.19 | Amiodarone is a cost-neutral way of preventing atrial fibrillation after surgery for lung cancer. ( Christensen, TD; Pilegaard, HK; Riber, LP, 2014) |
| "The patients in the amiodarone prophylaxis group had a reduction in the risk of atrial fibrillation of 23% (12 to 31); number needed to treat was 4." | 5.16 | Amiodarone significantly decreases atrial fibrillation in patients undergoing surgery for lung cancer. ( Christensen, TD; Hoejsgaard, A; Jensen, HK; Pilegaard, HK; Riber, LP, 2012) |
| " Overall atrial fibrillation occurred more frequently in the perioperative intravenous amiodarone group compared with the placebo group (59." | 5.14 | Perioperative intravenous amiodarone does not reduce the burden of atrial fibrillation in patients undergoing cardiac valvular surgery. ( Beaulieu, Y; Carrier, M; Couture, P; Denault, AY; Lambert, J; Levesque, S; O'Meara, E; Pagé, P; Roy, D; Talajic, M; Tardif, JC, 2010) |
| "In the AFIST III (Atrial Fibrillation Suppressions Trial III), anterior fat pad (AFP) retention did not decrease the incidence of postoperative atrial fibrillation (POAF), but prophylaxis with amiodarone did." | 5.13 | Impact of amiodarone on the ability of anterior fat pad retention to prevent postcoronary arterial bypass grafting atrial fibrillation incidence: a substudy of the AFIST III (Atrial Fibrillation Suppression Trial III). ( Coleman, CI; Dale, K; Gallagher, R; Henyan, N; Kluger, J; Reinhart, K; Sander, S; White, CM, 2008) |
| "The purpose of this study was to estimate the costs and health benefits of routinely administered postoperative amiodarone as prevention of atrial fibrillation for patients undergoing coronary artery bypass grafting (CABG) for stable angina." | 5.13 | Amiodarone cost effectiveness in preventing atrial fibrillation after coronary artery bypass graft surgery. ( Christensen, TD; Hjortdal, VE; Kristiansen, IS; Zebis, LR, 2008) |
| "The patients in amiodarone prophylaxis experienced a reduction in risk of atrial fibrillation of 14% (95% confidence interval [CI], 5." | 5.12 | Practical regimen for amiodarone use in preventing postoperative atrial fibrillation. ( Christensen, TD; Folkersen, L; Hjortdal, VE; Mikkelsen, MM; Sørensen, HT; Thomsen, HF; Zebis, LR, 2007) |
| "Postoperative intravenous amiodarone prophylaxis followed by oral amiodarone significantly reduces the incidence of atrial fibrillation after off-pump coronary artery bypass grafting and the ventricular rate during atrial fibrillation." | 5.12 | Intravenous and oral amiodarone for the prevention of postoperative atrial fibrillation in patients undergoing off-pump coronary artery bypass surgery. ( Ata, Y; Ozkan, H; Ozyazicioglu, A; Turk, T; Vural, H; Yavuz, S, 2007) |
| "Atrial fibrillation (AF) frequently occurs after cardiac surgical procedures, and beta-blockers, sotalol, and amiodarone may reduce the frequency of AF after open heart surgery." | 5.11 | A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo-controlled trial. ( Auer, J; Berent, R; Eber, B; Hartl, P; Lamm, G; Lassnig, E; Lehner, E; Ng, CK; Puschmann, R; Schwarz, C; Strasser, U; Weber, T, 2004) |
| "To compare the cost-effectiveness of intravenous plus oral amiodarone, atrial septal pacing, and both strategies combined to prevent atrial fibrillation after open heart surgery." | 5.11 | Economic analysis of intravenous plus oral amiodarone, atrial septal pacing, and both strategies to prevent atrial fibrillation after open heart surgery. ( Caron, MF; Coleman, CI; Horowitz, S; Kalus, JS; Karapanos, A; Kluger, J; Reddy, P; White, CM, 2004) |
| "We studied the use of perioperative IV and oral administration of amiodarone for the prevention of postoperative atrial fibrillation in patients undergoing coronary artery bypass graft surgery (CABG)." | 5.11 | Giving IV and oral amiodarone perioperatively for the prevention of postoperative atrial fibrillation in patients undergoing coronary artery bypass surgery: the GAP study. ( Hollander, G; Kerstein, J; Lichstein, E; Majid, M; Qamar, M; Shani, J; Soodan, A, 2004) |
| "This prospective, randomized, double-blind, placebo-controlled study compared the efficacy and safety of amiodarone and sotalol in the prevention of atrial fibrillation (AF) following open heart surgery." | 5.11 | Amiodarone versus sotalol for the treatment of atrial fibrillation after open heart surgery: the Reduction in Postoperative Cardiovascular Arrhythmic Events (REDUCE) trial. ( Arcidi, JM; Hilleman, DE; Lenz, TL; Mohiuddin, SM; Mooss, AN; Packard, KA; Rovang, KS; Sugimoto, JT; Wurdeman, RL, 2004) |
| "This study was designed to assess the effects of a perioperative dosing regimen of amiodarone administration, high thoracic epidural anesthesia (TEA), or a combination of the 2 regimens on atrial fibrillation (AF) after coronary artery bypass grafting (CABG)." | 5.11 | Effects of amiodarone and thoracic epidural analgesia on atrial fibrillation after coronary artery bypass grafting. ( Aldershvile, J; Eliasen, K; Hviid, LB; Krogsgaard, K; Nygård, E; Pedersen, FM; Ravn, J; Svendsen, JH; Sørensen, LH; Thomassen, L, 2004) |
| "To assess the prophylactic effect of postoperative oral amiodarone on the incidence and severity of atrial fibrillation (AF) after coronary artery surgery." | 5.10 | Postoperative oral amiodarone as prophylaxis against atrial fibrillation after coronary artery surgery. ( Haddad, F; Hayek, G; Madi-Jebara, S; Rahbani, P; Yazigi, A; Zeid, HA, 2002) |
| "The purpose of this study was to evaluate the safety and efficacy of postoperative administration of prophylactic amiodarone in the prevention of new-onset postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting." | 5.10 | Amiodarone reduces the incidence of atrial fibrillation after coronary artery bypass grafting. ( Apaydin, A; Atay, Y; Ayik, F; Buket, S; Calkavur, T; Islamoglu, F; Nalbantgil, S; Posacioglu, H; Yagdi, T, 2003) |
| "This pilot study aimed to compare right atrial pacing, intravenous amiodarone and oral beta-blockers in the prevention, time to onset, duration and effect on hospital stay of postoperative atrial fibrillation (AF) after coronary artery bypass graft surgery (CABG) at our center." | 5.10 | Effect of right atrial pacing, intravenous amiodarone and beta blockers for suppression of atrial fibrillation after coronary artery bypass surgery: a pilot study. ( Cardona, F; Cox, RA; Pérez, CM; Seide, H, 2003) |
| "This prospective randomized study aims at evaluation and comparison of the prophylactic effects of amiodarone versus digoxin and metoprolol combination in postcoronary bypass atrial fibrillation." | 5.10 | Amiodarone versus digoxin and metoprolol combination for the prevention of postcoronary bypass atrial fibrillation. ( Catav, Z; Gunaydin, S; Kandemir, O; Tokmakoglu, H; Yorgancioglu, C; Zorlutuna, Y, 2002) |
| "Intraoperative prophylactic use of amiodarone does not prevent new onset of atrial fibrillation in patients undergoing coronary artery bypass grafting and had no effect on outcome." | 5.09 | Intraoperative amiodarone as prophylaxis against atrial fibrillation after coronary operations. ( Dörge, H; Messmer, BJ; Schoberer, M; Schoendube, FA; Stellbrink, C; Voss, M, 2000) |
| "Atrial fibrillation occurred in 9 (12%) of the amiodarone group patients and in 26 (34%) of the control group patients during hospitalization (p < 0." | 5.09 | Intravenous amiodarone for prevention of atrial fibrillation after coronary artery bypass grafting. ( Chang, CM; Chen, SA; Cheng, JJ; Hung, CR; Lee, RJ; Lee, SH; Lu, MJ, 2000) |
| "Our aims were to examine whether the administration of amiodarone or magnesium sulphate after coronary artery bypass graft surgery (CABG) could reduce the occurrence of atrial fibrillation, and to identify the risk factors associated with atrial fibrillation after CABG." | 5.09 | Intravenous amiodarone or magnesium sulphate is not cost-beneficial prophylaxis for atrial fibrillation after coronary artery bypass surgery. ( Adamec, R; Perneger, TV; Romand, JA; Suter, PM; Treggiari-Venzi, MM; Waeber, JL, 2000) |
| "Of the 100 patients recruited for the Amiodarone arm of the study, 12 were excluded for a variety of reasons detailed in the discussion with atrial fibrillation occurring in 28 (a rate of 32%)." | 5.09 | Effect of amiodarone on atrial fibrillation after coronary artery bypass surgery. ( Harahsheh, BS; Sawalha, WA, 2001) |
| "Both amiodarone and beta-blockers have been shown to decrease the incidence of atrial fibrillation after cardiovascular surgery." | 5.09 | Amiodarone versus a beta-blocker to prevent atrial fibrillation after cardiovascular surgery. ( Greenberg, MD; Katz, NM; Kilborn, MJ; Solomon, AJ, 2001) |
| "The safety and efficacy of amiodarone and propafenone in converting atrial fibrillation or flutter after cardiac surgery were compared in a randomized double-blind trial." | 5.08 | Intravenous amiodarone vs propafenone for atrial fibrillation and flutter after cardiac operation. ( Cappiello, E; Di Biasi, P; Mangini, A; Paje, A; Santoli, C; Scrofani, R, 1995) |
| "Atrial fibrillation occurred in 15% of the patients receiving placebo and in 8% of the patients receiving verapamil (difference not significant)." | 5.08 | Verapamil as prophylactic treatment for atrial fibrillation after lung operations. ( Demedts, M; Demuynck, K; Deneffe, G; Lacquet, L; Tits, G; Tjandra-Maga, T; Van Mieghem, W, 1996) |
| "Postoperative atrial fibrillation occurred in 16 of the 64 patients in the amiodarone group (25 percent) and 32 of the 60 patients in the placebo group (53 percent) (P=0." | 5.08 | Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. ( Bitar, C; Bolling, SF; Daoud, EG; Deeb, GM; Goyal, R; Man, KC; Meissner, MD; Morady, F; Pagani, FD; Strickberger, SA, 1997) |
| " We set out to compare the relative efficacy of amiodarone and digoxin in the management of atrial fibrillation and flutter in the early postoperative period." | 5.07 | A comparison of amiodarone and digoxin for treatment of supraventricular arrhythmias after cardiac surgery. ( Cochrane, AD; Davis, BB; Marasco, S; McConaghy, L; Rosenfeldt, FL; Salamonsen, R; Siddins, M, 1994) |
| "The incidence of clinically significant tachycardia was reduced by amiodarone." | 5.07 | Amiodarone prophylaxis for tachycardias after coronary artery surgery: a randomised, double blind, placebo controlled trial. ( Butler, J; Harriss, DR; Sinclair, M; Westaby, S, 1993) |
| "An evaluation of amiodarone as prophylactic treatment for supraventricular tachyarrhythmias after pulmonary surgery was stopped because of a high incidence of the adult respiratory distress syndrome (ARDS) after a pneumonectomy." | 5.07 | Amiodarone and the development of ARDS after lung surgery. ( Coolen, L; Demedts, MG; Deneffe, GJ; Lacquet, LM; Malysse, I; Van Mieghem, W, 1994) |
| "Although many patients waiting for heart transplantation will die of arrhythmias before a donor heart is found, the use of amiodarone has been limited by concern about increased complications in the perioperative period." | 5.07 | Amiodarone therapy does not compromise subsequent heart transplantation. ( Brownfield, ED; Chelimsky-Fallick, C; Drinkwater, D; Hamilton, MA; Kobashigawa, J; Laks, H; Middlekauff, HR; Moriguchi, J; Saxon, LA; Stevenson, WG, 1992) |
| " The question addressed was whether the administration of amiodarone is safe in patients undergoing lung resection either for prophylaxis or treatment of de novo postoperative atrial fibrillation (POAF)." | 4.95 | In patients undergoing lung resection is it safe to administer amiodarone either as prophylaxis or treatment of atrial fibrillation? ( Billè, A; Harling, L; Kolokotroni, SM; Toufektzian, L, 2017) |
| "Despite probably being the most effective prophylactic drug for postoperative atrial fibrillation (POAF), amiodarone is reserved as a second-line agent because of its potential systemic side effects." | 4.93 | Intrapericardial Amiodarone for the Prevention of Postoperative Atrial Fibrillation. ( Chu, FV; Habbab, LM, 2016) |
| "Amiodarone remains one of the preferred antiarrhythmic medications for patients with advanced heart failure awaiting cardiac transplant." | 4.91 | Impact of pre-implant amiodarone exposure on outcomes in cardiac transplant recipients. ( Jennings, DL; Lanfear, DE; Martinez, B; Montalvo, S, 2015) |
| "Current guidelines recommend beta-blocker as the first-line preventive treatment of atrial fibrillation (AF) after cardiac surgery; if beta-blocker therapy is contraindicated, then amiodarone is recommended." | 4.88 | Meta-analysis of amiodarone versus β-blocker as a prophylactic therapy against atrial fibrillation following cardiac surgery. ( Gao, D; Gao, Y; Lu, Y; Wang, C; Zhang, C; Zhang, Y; Zhu, J, 2012) |
| "To investigate a possible dose-response relationship between amiodarone and reduction in incidence of postoperative atrial fibrillation, and to determine whether pre- or postoperative initiation of amiodarone is superior." | 4.84 | Amiodarone prophylaxis for atrial fibrillation after cardiac surgery: meta-analysis of dose response and timing of initiation. ( Buckley, MS; Copeland, JG; Hilleman, DE; Nolan, PE; Slack, MK; Tisdale, JE, 2007) |
| "A meta-analysis was conducted to assess the safety of amiodarone in the prevention of postoperative atrial fibrillation." | 4.83 | Safety of amiodarone in the prevention of postoperative atrial fibrillation: a meta-analysis. ( Coleman, CI; Gillespie, EL; Kluger, J; Patel, AA; White, CM, 2006) |
| " Amiodarone can effectively prevent and control postoperative atrial and ventricular fibrillation." | 4.82 | Hepatotoxicity during rapid intravenous loading with amiodarone: Description of three cases and review of the literature. ( Drewe, J; Krähenbühl, S; Pargger, H; Rätz Bravo, AE; Schlienger, RG; Ummenhofer, W, 2005) |
| "Two previous meta-analyses of amiodarone for prevention of postoperative atrial fibrillation (POAF) after cardiothoracic surgery did not evaluate total hospital cost, concluded that data on stroke are incomplete, and did not evaluate the effect of clinical heterogeneity between trials." | 4.82 | Effect of prophylactic amiodarone on clinical and economic outcomes after cardiothoracic surgery: a meta-analysis. ( Coleman, CI; Gillespie, EL; Gryskiewicz, KA; Kluger, J; Sander, S; White, CM, 2005) |
| "The association between amiodarone treatment for postoperative atrial fibrillation (POAF) after surgical aortic valve replacement (SAVR) and both the return to normal sinus rhythm (NSR) and anticoagulation use at discharge has not been extensively studied." | 4.31 | Postoperative Atrial Fibrillation After Surgical Aortic Valve Replacement: Amiodarone and Warfarin Use. ( Beaulieu-Jones, BR; Haime, M; Lin, B; Phillips, AM; Quin, JA, 2023) |
| " Repeat CT chest after 2 weeks for recurrent cough showed a small PE, treated with oral prednisone for suspected postablation pericarditis, with complete resolution of cough." | 3.88 | Cough as the sole manifestation of pericardial effusion. ( Abdullah, O; Fong, HK; Gautam, S, 2018) |
| "Amiodarone frequently is used in patients with heart failure." | 3.85 | To use or not to use? Amiodarone before heart transplantation. ( Akhter, S; Badami, A; Chindhy, S; Dhingra, R; Kohmoto, T; Lozonschi, L; Lushaj, EB; Osaki, S; Ulschmid, S, 2017) |
| "The authors assessed the efficacy and safety of landiolol, an ultra-short-acting beta-blocker, with those of amiodarone in the restoration of sinus rhythm for postoperative atrial fibrillation (POAF) in intensive care unit (ICU) patients." | 3.83 | Efficacy and Safety of Landiolol Compared to Amiodarone for the Management of Postoperative Atrial Fibrillation in Intensive Care Patients. ( Fujino, Y; Ohta, N; Shibata, SC; Uchiyama, A, 2016) |
| "The aim of this study was to investigate the effects of long-term use of amiodarone before HTX on early post-transplant atrial fibrillation (AF) and mortality after HTX." | 3.83 | Long-term use of amiodarone before heart transplantation significantly reduces early post-transplant atrial fibrillation and is not associated with increased mortality after heart transplantation. ( Akhavanpoor, M; Bruckner, T; Darche, FF; Doesch, AO; Ehlermann, P; Erbel, C; Frankenstein, L; Gleissner, CA; Helmschrott, M; Katus, HA; Rivinius, R; Ruhparwar, A; Schmack, B; Schweizer, PA; Thomas, D, 2016) |
| "We investigated the effect of amiodarone (AMD) administered intravenously for the treatment of post-operative atrial fibrillation( POAF) after cardiac surgery." | 3.80 | [Therapeutic use of amiodarone against postoperative fibrillation after cardiac surgery]. ( Araki, E; Kawaharada, N; Muraki, S; Nakashima, S; Osawa, H; Sakurada, T; Sasaki, J, 2014) |
| "We evaluated the association of respiratory complications and amiodarone use in patients with atrial fibrillation (AF) after major lung resection." | 3.80 | Use of amiodarone after major lung resection. ( Berry, MF; D'Amico, TA; Onaitis, MW, 2014) |
| "We prospectively collected cases of amiodarone-associated thyrotoxicosis requiring thyroidectomy due to failure of antithyroid treatment, despite amiodarone discontinuation." | 3.78 | Total thyroidectomy for amiodarone-associated thyrotoxicosis: should surgery always be delayed for pre-operative medical preparation? ( Duverger, V; Merat, S; Perrier, E; Pierret, C; Pons, Y; Tourtier, JP, 2012) |
| "Patients with amiodarone-induced thyrotoxicosis (AIT) and left ventricular (LV) systolic dysfunction have a high mortality rate." | 3.78 | Total thyroidectomy in patients with amiodarone-induced thyrotoxicosis and severe left ventricular systolic dysfunction. ( Bartalena, L; Bogazzi, F; De Napoli, L; Marchello, A; Mariotti, R; Martino, E; Materazzi, G; Miccoli, P; Moretti, M; Rossi, G; Tomisti, L, 2012) |
| " After administration of atorvastatin, amiodarone, and fluconazole, rhabdomyolysis developed with electrolyte disturbances (hyperphosphatemia, hyopcalcemia) and a massive increase in creatine kinase and myoglobin." | 3.77 | [Rhabdomyolysis associated with atorvastatin combined with amiodarone and fluconazole]. ( Bruggisser, M; Franz, CC; Krähenbühl, S; Rätz Bravo, AE, 2011) |
| "We investigated the effect of amiodarone on prevention of post-operative atrial fibrillation (POAF) after cardiac surgery." | 3.77 | [Prophylactic use of amiodarone against postoperative atrial fibrillation after cardiac surgery]. ( Araki, E; Osawa, H; Sakurada, T; Sasaki, J, 2011) |
| " Patient had atrial fibrillation on 3rd post-operative day requiring loading dose of amiodarone followed by maintenance dose to control the arrhythmia." | 3.77 | Ultra-short course of low-dose amiodarone-induced post-operative fatal pulmonary toxicity. ( Nair, SG; Patel, V; Viswam, D, 2011) |
| " Patients with symptomatic new-onset atrial fibrillation or lasting >15 minutes were treated with amiodarone and with DC shock in prolonged cases." | 3.76 | Atrial fibrillation after cardiac surgery: incidence, risk factors, and economic burden. ( Braconi, L; Carone, E; Gelsomino, S; Gensini, GF; Ghilli, L; La Meir, M; Maessen, J; Mattesini, A; Padeletti, L; Puggelli, F; Rossi, A; Rosso, G; Rostagno, C; Stefàno, PL, 2010) |
| "Amiodarone is widely used in Europe and the United States for refractory ventricular fibrillation (VF) in various situations, such as VF after myocardial infarction or out-of-hospital cardiac arrest." | 3.76 | [Successful use of intravenous amiodarone for refractory ventricular fibrillation just after releasing aortic cross-clamp]. ( Iwasaki, T; Kanazawa, T; Matsuoka, M; Morimatsu, H; Morita, K; Shimizu, K; Suemori, T; Suzuki, S; Toda, Y; Yokoi, N, 2010) |
| "Evidence from multiple trials demonstrates the efficacy of prophylactic beta-blocker, amiodarone, and corticosteroid administration in reducing the incidence of postoperative atrial fibrillation." | 3.75 | Current use of prophylactic strategies for postoperative atrial fibrillation: a survey of Canadian cardiac surgeons. ( Green, MS; Hendry, P; Lam, BK; Price, J; Rubens, FD; Tee, R, 2009) |
| "In a 10-year prospective observational study, 71 of 2651 patients (2885 procedures, 2106 bypass procedures) received amiodarone for newly detected postoperative atrial (n = 70) or ventricular (n = 7) tachyarrhythmia: early treatment (initiation within 60 minutes of arrhythmia detection) and late treatment (after that)." | 3.74 | Impact of early and standardized treatment with amiodarone on therapeutic success and outcome in pediatric patients with postoperative tachyarrhythmia. ( Camphausen, CK; Haas, NA, 2008) |
| "To assess if prophylaxis with moderate doses of amiodarone in the postoperative period of cardiac surgery (coronary artery bypass grafting and/or valve surgery), reduces the incidence of atrial fibrillation in patients with high risk for developing this arrhythmia." | 3.74 | Prevention of atrial fibrillation with moderate doses of amiodarone in the postoperative period of cardiac surgery is safe and effective in patients with high risk for developing this arrhythmia. ( Alves, RJ; Brito, Gd; Geovanini, GR; Glauser, VA; Miguel, GA; Nakiri, K, 2007) |
| "To evaluate the effect of prophylactic amiodarone on length of stay (LOS), postoperative stroke, and postoperative atrial fibrillation (POAF)." | 3.73 | Impact of prophylactic amiodarone on length of hospital stay, stroke, and atrial fibrillation after cardiothoracic surgery. ( Coleman, CI; Gillespie, EL; Ismaili, A; Kardas, M; Kluger, J; Perkerson, KA; Takata, H; White, CM, 2005) |
| "Amiodarone can induce severe hyperthyroidism that justifies its withdrawal and initiation of antithyroid drugs." | 3.72 | [Anaesthesia and amiodarone-associated hyperthyroidism]. ( Bonnevie, L; Lambert, E; Lenoir, B; Mérat, S; Pats, B; Perrier, E, 2004) |
| "This study evaluated the cost-effectiveness of administering prophylactic intravenous (IV) amiodarone therapy to patients undergoing cardiac surgery according to their predicted risk of postoperative atrial fibrillation." | 3.71 | Cost-effectiveness of targeting patients undergoing cardiac surgery for therapy with intravenous amiodarone to prevent atrial fibrillation. ( Mahoney, EM; Thompson, TD; Veledar, E; Weintraub, WS; Williams, J, 2002) |
| "Of the 347 patients who underwent thyroidectomy, 54 (16%) had thyrotoxicosis, secondary to Graves' disease (32 patients), toxic multinodular goiter (18 patients), thyroiditis (2 patients), or amiodarone (2 patients)." | 3.71 | Thyroidectomy for selected patients with thyrotoxicosis. ( McHenry, CR; Mittendorf, EA, 2001) |
| "A patient with mechanical heart valves developed bleeding, after the introduction of amiodarone and azithromycin." | 3.70 | Bleeding complication during coumarin therapy due to amiodarone and azithromycin. ( Bharat, V; Mohanty, B, 2000) |
| "To report our experience using high dose oral amiodarone (1,800 mg/day) for the reversion of atrial fibrillation to sinus rhythm in patients submitted to cardiac surgery." | 3.69 | [Use of high-dose oral amiodarone for the reversion of atrial fibrillation during the postoperative period of cardiac surgery]. ( Bodanese, LC; Brauner, FB; Brunini, TM; Guaragna, JC; Linhatti, JL; Martins, V; Pires, RC, 1997) |
| "Amiodarone-induced thyrotoxicosis (AIT) is a rare disorder that is frequently refractory to conventional pharmacologic therapy." | 3.68 | Amiodarone-induced thyrotoxicosis: clinical presentation and expanded indications for thyroidectomy. ( Esselstyn, CB; Kinney, W; McHenry, CR; Mulligan, DC, 1993) |
| " We present the case of a 12-year-old postoperative Mustard patient who developed biventricular heart failure due to an atrial ectopic tachycardia resistant to amiodarone." | 3.68 | Successful catheter fulguration of the His bundle in a postoperative Mustard patient after unsuccessful fulguration of ectopic atrial foci. ( Case, CL; Gillette, PC; Greene, CA, 1991) |
| "Directed surgical intervention in patients with ventricular tachyarrhythmias who have experienced failure of amiodarone therapy is a common clinical scenario." | 3.68 | Amiodarone-related postoperative adult respiratory distress syndrome. ( Greenspon, AJ; Hurley, W; Kidwell, GA; Mannion, J, 1991) |
| "Iodine-induced hyperthyroidism has been frequently described when iodine is introduced into an iodine-deficient area." | 3.67 | Five patients with iodine-induced hyperthyroidism. ( Braverman, LE; Mordes, JP; Rajatanavin, R; Safran, M; Stoller, WA, 1984) |
| "Amiodarone therapy for cardiac arrhythmias is increasingly being recognized to be associated with pulmonary toxicity." | 3.67 | Life-threatening postoperative pulmonary complications in patients with previous amiodarone pulmonary toxicity undergoing cardiothoracic operations. ( Fishbein, MC; Gang, ES; Kass, RM; Mandel, WJ; Nalos, PC; Peter, T, 1987) |
| "Amiodarone has been conventionally used in its treatment." | 3.01 | Ivabradine Versus Amiodarone in the Management of Postoperative Junctional Ectopic Tachycardia: A Randomized, Open-Label, Noninferiority Study. ( Arvind, B; Chowdhury, UK; Devagourou, V; Gupta, SK; Hote, MP; Juneja, R; Kothari, SS; Rajashekar, P; Ramakrishnan, S; Sahu, MK; Saxena, A; Singh, SP; Talwar, S, 2021) |
| " Prophylactic amiodarone is safe and effective in preventing early JET in children after open heart surgery." | 2.82 | Safety and Efficacy of Prophylactic Amiodarone in Preventing Early Junctional Ectopic Tachycardia (JET) in Children After Cardiac Surgery and Determination of Its Risk Factor. ( Amrousy, DE; Elshehaby, W; Elshmaa, NS; Feky, WE, 2016) |
| "Treatment with bisoprolol resulted in a trend to lower ventricular response rate in AF cases." | 2.74 | Postoperative oral amiodarone versus oral bisoprolol as prophylaxis against atrial fibrillation after coronary artery bypass graft surgery: a prospective randomized trial. ( Ashoush, R; El Rassi, I; Haddad, F; Hayeck, G; Jebara, V; Madi-Jebara, S; Sleilaty, G; Yazigi, A, 2009) |
| "Propafenone was given to Group 1 (G1); sotalol to Group 2 (G2); amiodarone to Group 3 (G3) and diltiazem to Group 4 (G4) at doses of 300 mg/day, 80 mg/day, 400 mg/day and 180 mg/day orally respectively." | 2.73 | [The comparison between the efficiency of different anti-arrhythmic agents in preventing postoperative atrial fibrillation after open heart surgery]. ( Aytekin, S; Aytekin, V; Men, EE; Tuğcu, A; Yildirimtürk, O, 2008) |
| "Amiodarone is a drug frequently used for cardioversion." | 2.73 | Does stopping amiodarone after successfully treating atrial fibrillation occurring after cardiac surgery increase the risk of recurrence? ( Attaran, S; Desai, J; El-Gamel, A; John, L; Sherwood, R, 2008) |
| "Amiodarone was given as 600 mg oral single dose one day before and from days 2 through 7 after surgery." | 2.72 | Amiodarone prophylaxis for atrial fibrillation of high-risk patients after coronary bypass grafting: a prospective, double-blinded, placebo-controlled, randomized study. ( Budeus, M; Erbel, R; Feindt, P; Felix, O; Gams, E; Hennersdorf, M; Lehmann, N; Perings, C; Perings, S; Reimert, K; Röhlen, S; Sack, S; Schnitzler, S; Wieneke, H, 2006) |
| "Amiodarone treated patients had a lower incidence of AF (22." | 2.71 | Amiodarone prevents symptomatic atrial fibrillation and reduces the risk of cerebrovascular accidents and ventricular tachycardia after open heart surgery: results of the Atrial Fibrillation Suppression Trial (AFIST). ( Kluger, J; White, CM, 2003) |
| "The amiodarone dosage was lowered to 200 mg/day in the sixth postoperative week." | 2.71 | Effects of late regain of sinus rhythm on pulmonary artery pressure and functional status in patients with mitral valve replacement surgery and atrial fibrillation. ( Demircioglu, F; Ersel, F; Gölbasi, I; Kabukcu, M; Yanik, E, 2004) |
| "Many patients with paroxysmal atrial fibrillation (AF) become refractory to antiarrhythmic drugs (AADs)." | 2.71 | Hybrid therapy with right atrial catheter ablation and previously ineffective antiarrhythmic drugs for the management of atrial fibrillation. ( Block, JE; Calkins, H; Cher, D; Kocheril, AG; Sharma, AD; Stubbs, HA, 2005) |
| "Several cardiac complications, such as pulmonary edema, temporary pacing, and need for intraaortic balloon pump counterpulsation, were observed more frequently in amiodarone-treated patients than in control patients." | 2.68 | Low-dose amiodarone-related complications after cardiac operations. ( Cokkinos, DV; Daganou, M; Dimopoulou, I; Geroulanos, S; Khoury, M; Marathias, K; Prapas, S; Stavridis, G, 1997) |
| "Amiodarone therapy has been implicated as a risk factor for cardiothoracic surgical procedures." | 2.67 | Are patients receiving amiodarone at increased risk for cardiac operations? ( Butany, J; Downar, E; Maruyama, H; Mickleborough, LL; Mohamed, S; Rappaport, DC; Sun, Z, 1994) |
| "Amiodarone was given after surgery in a loading bolus of 300 mg for 2 hours followed by 1200 mg every 24 hours for 2 days and 900 mg every 24 hours for the next 2 days." | 2.67 | Electrocardiographic and antiarrhythmic effects of intravenous amiodarone: results of a prospective, placebo-controlled study. ( Dammbacher, T; Fraedrich, G; Hohnloser, SH; Jähnchen, E; Just, H; Meinertz, T; Steiert, K; Zehender, M, 1991) |
| "Amiodarone concentration was lower in red blood cells than in plasma and in myocardium." | 2.66 | Amiodarone and N-desethylamiodarone concentrations in plasma, red blood cells, and myocardium after a single oral dose: relation to hemodynamic effects in surgical patients. ( Berger, Y; Commin, P; Echter, E; Escoubet, B; Jaillon, P; Menasché, P; Piwnica, A, 1986) |
| "Amiodarone can cause toxicity in several organs, including amiodarone-induced pulmonary toxicity which is a subacute or chronic complication." | 2.53 | Acute Amiodarone Pulmonary Toxicity After Surgical Procedures. ( Chariyawong, P; Nugent, K; Tantrachoti, P; Teerakanok, J, 2016) |
| "Amiodarone plays a pivotal role in the treatment of ventricular and supraventricular arrhythmias." | 2.50 | [Total thyroidectomy in patients with amiodarone-induced hyperthyroidism: when does the risk of conservative treatment exceed the risk of surgery?]. ( Greutmann, M; Huber, GF; Meerwein, C; Schmid, C; Vital, D, 2014) |
| "Arrhythmogenic right ventricular cardiomyopathy is a genetic cardiomyopathy characterized by replacement of right ventricular myocardium by fibrofatty infiltrates, leading to significant ventricular arrhythmias with sudden death and right ventricular dysfunction." | 2.50 | [Anesthetic management of patients with arrhythmogenic right ventricular cardiomyopathy]. ( Kato, Y, 2014) |
| "The diagnosis of Junctional Ectopic Tachycardia can be made on a 12-lead ECG, demonstrating a narrow-complex tachycardia with inverted P-waves and VA dissociation." | 2.50 | Junctional ectopic tachycardia after congenital heart surgery. ( Cools, E; Missant, C, 2014) |
| " Inconsistent prescribing practices, variable dosage regimens, and a lack of consensus regarding the appropriate use of amiodarone prompted the need for developing practice guidelines." | 2.44 | Amiodarone for atrial fibrillation following cardiac surgery: development of clinical practice guidelines at a university hospital. ( Khanderia, U; Prager, R; Wagner, D; Walker, PC; Woodcock, B, 2008) |
| "Amiodarone and early CVN was more effective than nonamiodarone therapies with regard to restoring NSR for patients in whom AF developed after elective CABG." | 2.43 | Selective use of amiodarone and early cardioversion for postoperative atrial fibrillation. ( Holmes, EC; Samuels, FL; Samuels, LE, 2005) |
| "Recurrent sustained ventricular tachycardia and ventricular fibrillation in the acute phase after cardiac surgery is the most lethal arrhythmia and may warrant acute intervention and aggressive treatment." | 2.41 | [Management of lethal ventricular arrhythmias after cardiac surgery]. ( Ohnishi, S, 2002) |
| "Cardiac arrhythmias are common in the perioperative period." | 2.41 | Postoperative arrhythmias and conduction disorders. ( Sloan, SB; Weitz, HH, 2001) |
| "Both amiodarone and sotalol were more effective than placebo treatment in reducing the incidence of postoperative AFF." | 2.41 | Amiodarone vs. sotalol as prophylaxis against atrial fibrillation/flutter after heart surgery: a meta-analysis. ( Lenz, TL; Mohiuddin, SM; Mooss, AN; Wurdeman, RL, 2002) |
| "Sotalol has a rapid onset of action, allowing it to be efficacious when used orally shortly after surgery." | 2.40 | Prevention of atrial fibrillation in the postoperative cardiac patient: significance of oral class III antiarrhythmic agents. ( Morady, F, 1999) |
| "Polymorphic ventricular tachycardia (VT) without QT prolongation is well described in patients without structural heart disease (mainly idiopathic ventricular fibrillation and Brugada syndrome) and in patients with acute ST-elevation myocardial infarction." | 1.51 | Quinidine-Responsive Polymorphic Ventricular Tachycardia in Patients With Coronary Heart Disease. ( Amit, G; Asher, E; Belhassen, B; Chorin, E; Halkin, A; Havakuk, O; Hochstadt, A; Laish-Farkash, A; Lee, JK; Rosso, R; Tovia-Brodie, O; Viskin, D; Viskin, S, 2019) |
| "VT recurrence was higher for >1RFA vs 1RFA (29% vs 24%, P <." | 1.46 | Outcomes after repeat ablation of ventricular tachycardia in structural heart disease: An analysis from the International VT Ablation Center Collaborative Group. ( Bunch, TJ; Burkhardt, JD; Callans, DJ; Della Bella, P; Di Biase, L; Dickfeld, T; Frankel, DS; Lakkireddy, D; Marchlinski, FE; Mathuria, N; Nakahara, S; Natale, A; Santangeli, P; Sauer, WH; Shivkumar, K; Stevenson, WG; Tedrow, U; Tholakanahalli, VN; Tung, R; Tzou, WS; Vakil, K; Vaseghi, M; Vergara, P; Vunnam, R; Weiss, JP, 2017) |
| " Significant disagreement was found concerning the timing and sequential order of additional therapeutic measures and particularly about the dosing of amiodarone and the role of R-wave synchronized atrial pacing." | 1.46 | Management of postoperative junctional ectopic tachycardia in pediatric patients: a survey of 30 centers in Germany, Austria, and Switzerland. ( Egender, F; Entenmann, A; Gass, M; Gebauer, R; Haas, N; Herberg, U; Kumpf, M; Michel, M, 2017) |
| "Amiodarone-treated patients were older and more frequently had a history of sudden cardiac death (27% vs 13%) and pre-OHT mechanical circulatory support." | 1.46 | Amiodarone use in patients listed for heart transplant is associated with increased 1-year post-transplant mortality. ( Cooper, LB; Edwards, LB; Hernandez, AF; Lund, LH; Mentz, RJ; Milano, CA; Patel, CB; Rogers, JG; Stehlik, J; Wilk, AR, 2017) |
| "Neurogenic stunned myocardium is an unusual clinical entity." | 1.42 | [Neurogenic stunned myocardium in Pediatrics. A case report]. ( Alados Arboledas, FJ; Expósito-Montes, JF; Martínez Padilla, MC; Millán-Bueno, MP; Millán-Miralles, L; Santiago-Gutierrez, C, 2015) |
| "The incidence of junctional ectopic tachycardia was 37% in the control group and 10% in the amiodarone group." | 1.38 | Prophylactic amiodarone reduces junctional ectopic tachycardia after tetralogy of Fallot repair. ( Dossey, AM; Garcia, X; Imamura, M; Jaquiss, RD; Shinkawa, T, 2012) |
| "A radiograph demonstrated pulmonary edema; echocardiography revealed an ostium secundum atrial septal defect with increased flow to the lung and severe pulmonary hypertension." | 1.37 | [Postoperative management of postpneumonectomy pulmonary edema in a patient with ostium secundum atrial septal defect]. ( Barberá, M; Marchante, M; Navarro, JL; Ramos, F; Vicente, R, 2011) |
| "When landiolol was administered, enough attention should be paid to the patients whose left ventricular function was low." | 1.36 | [Clinical analysis of precaution against atrial fibrillation following cardiac surgery: landiolol or amiodarone?]. ( Abe, T; Fukuda, T; Haruna, T; Inoko, M; Ito, H; Miyamoto, S; Nakane, E; Nohara, R; Sasaki, K; Uehara, K; Ueyama, K, 2010) |
| "Flecainide is an antiarrhythmic drug that blocks sodium channels during phase 0 of cardiac action potential, delaying conduction and reducing contractility." | 1.36 | [Flecainide poisoning]. ( Bobillo, B; Diz Gómez, JC; Doniz Campos, M; Filgueira, P; Illodo Miramontes, G; Otero Amoedo, T; Rey López, F, 2010) |
| "Amiodarone was suggested to be an adequate treatment; however, data regarding its efficacy and safety are limited." | 1.35 | Amiodarone as a first-line therapy for postoperative junctional ectopic tachycardia. ( Dobos, D; Hakacova, N; Kovacikova, L; Skrak, P; Zahorec, M, 2009) |
| "Intercurrent runs of ectopic atrial tachycardia made atrial pacing impossible, despite high doses of intravenous amiodarone." | 1.33 | Successful use of an intravenous infusion of flecainide and amiodarone for a refractory combination of postoperative junctional and ectopic tachycardias. ( Fox, S; Haas, NA; Skinner, JR, 2005) |
| "Ventricular tachycardia is one of the most feared complications after surgical repair of Tetralogy of Fallot and it is associated with sudden death." | 1.33 | [Radiofrequency ablation of ventricular tachycardia in a patient after surgery for Tetralogy of Fallot: case report]. ( Baeza, M; Fajuri, A; Frangini, P; González, R; Vergara, I, 2005) |
| "High recurrence rate is still a major problem associated with ablation of paroxysmal atrial fibrillation (AF)." | 1.32 | Clinical outcome of very late recurrence of atrial fibrillation after catheter ablation of paroxysmal atrial fibrillation. ( Chan, P; Chang, MS; Chen, SA; Ding, YA; Hsieh, MH; Huang, JL; Lin, WS; Lin, YK; Tai, CT; Tsai, CF; Tsao, HM; Ueng, KC; Yu, WC, 2003) |
| " Amiodarone infusion (mean dosage 24 h: 1625+/-528 mg; 48 h: 2708+/-895 mg) restored sinus rhythm in 54% of study patients within 12 h, in 64% within 24 h, and in 75% within 48 h." | 1.32 | High-dosage continuous amiodarone therapy to treat new-onset supraventricular tachyarrhythmias in surgical intensive care patients: an observational study. ( Dünser, MW; Friesenecker, B; Hasibeder, WR; Knotzer, H; Mayr, AJ; Pajk, W; Ritsch, N; Ulmer, H; Wenzel, V, 2004) |
| "Flutter-like arrhythmias occur mainly after atrial surgery (closure of atrial septal defects, Mustard, Senning or Fontan procedures)." | 1.31 | [Arrhythmias after surgery for congenital heart disease]. ( Lucet, V, 2002) |
| "Amiodarone was administered to those who developed SA with a loading dose of 5 mg/kg in 30 min and a maintenance dose of 15 mg/kg in 24 h." | 1.31 | Supraventricular arrhythmia following lung resection for non-small cell lung cancer and its treatment with amiodarone. ( Canneto, B; Ciriaco, P; Mazzone, P; Zannini, P, 2000) |
| "To evaluate treatment of junctional ectopic tachycardia after cardiac surgery." | 1.31 | [The treatment of postoperative junctional ectopic tachycardia]. ( Cabrera Duro, A; Galdeano Miranda, JM; Macua Biurrun, P; Martínez Corrales, P; Pastor Menchaca, E; Pilar Orive, J; Rodrigo Carbonero, D, 2002) |
| "Amiodarone did not increase the incidence of acute organ dysfunction or death after cardiac surgery." | 1.30 | Preoperative therapy with amiodarone and the incidence of acute organ dysfunction after cardiac surgery. ( Rady, MY; Ryan, T; Starr, NJ, 1997) |
| " However, because the discoloration developed before surgery and was bilateral, long-term administration of amiodarone may also have played a role." | 1.30 | Progressive brown discoloration of silicone intraocular lenses after vitrectomy in a patient on amiodarone. ( Katai, N; Yokoyama, R; Yoshimura, N, 1999) |
| "Amiodarone 5 mg/kg was administered intravenously over one hour and the same dose was subsequently infused over 12 hours." | 1.29 | Amiodarone management of junctional ectopic tachycardia after cardiac surgery in children. ( Cartmill, TB; Chaikitpinyo, A; Cooper, SG; Hawker, RE; Lau, KC; Nunn, GR; Raja, P; Sholler, GF, 1994) |
| " After restoration of sinus rhythm, several therapeutic protocols were used, often in the same patient: abstention, leading to 5 recurrences in 6 cases; treatment with betablockers in 12 patients with well tolerated or exercise-induced atrial tachycardia with 11 successes; amiodarone, with 4 relapses out of 5 when the dosage was less than 200 mg/m2/day and 13 successes out of 18 when the dosage was 200-250 mg/m2/day." | 1.29 | [Treatment and prognosis of tachyarrhythmia after atrial surgical repair of transposition of great vessels]. ( Aggoun, Y; Bonnet, D; Iserin, L; Kachaner, J; Sidi, D; Villain, E, 1996) |
| "In amiodarone-treated patients, the major findings were as follows: a 50% incidence of hepatic dysfunction with a tenfold increase in concentrations of serum glutamic-oxaloacetic transaminase and serum glutamic-pyruvic transaminase; a 25% incidence of pulmonary dysfunction necessitating a fourfold increase in the number of days of ventilator support; and a 19% incidence of low cardiac output syndrome with two deaths." | 1.28 | Amiodarone-induced complications after cardiac operation for obstructive hypertrophic cardiomyopathy. ( Clark, RE; Kupferschmid, JP; Leon, MB; McIntosh, CL; Rosengart, TK, 1989) |
| "Amiodarone was administered in five patients with life-threatening ventricular arrhythmias resistant to other antiarrhythmic agents: Suppression was obtained in one of two patients with recurrent ventricular tachycardias and control was achieved in three patients with repetitive ventricular tachycardia and ventricular fibrillation, allowing the effective use of intra-aortic balloon counterpulsation (IABP) needed for hemodynamic support." | 1.26 | Intravenous amiodarone in the treatment of various arrhythmias following cardiac operations. ( Charles, S; Gadisseux, P; Installe, E; Schoevaerdts, JC; Tremouroux, J, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (4.53) | 18.7374 |
| 1990's | 44 (18.11) | 18.2507 |
| 2000's | 109 (44.86) | 29.6817 |
| 2010's | 70 (28.81) | 24.3611 |
| 2020's | 9 (3.70) | 2.80 |
| Authors | Studies |
|---|---|
| Amar, D | 1 |
| Zhang, H | 1 |
| Chung, MK | 1 |
| Tan, KS | 1 |
| Desiderio, D | 1 |
| Park, BJ | 1 |
| Pedoto, A | 1 |
| Roistacher, N | 1 |
| Isbell, JM | 1 |
| Molena, D | 1 |
| Milne, GL | 1 |
| Meyers, BF | 1 |
| Fischer, GW | 1 |
| Rusch, VW | 1 |
| Jones, DR | 1 |
| Zhang, J | 1 |
| Wang, Y | 1 |
| Jiang, H | 1 |
| Tao, D | 1 |
| Zhao, K | 1 |
| Yin, Z | 1 |
| Han, J | 1 |
| Xin, F | 1 |
| Jin, Y | 1 |
| Wang, H | 1 |
| Chen, X | 3 |
| Sartor, C | 3 |
| Zhang, S | 3 |
| Baranchuk, A | 3 |
| Ross-White, A | 3 |
| Fernandez, AL | 3 |
| El-Diasty, M | 3 |
| Beaulieu-Jones, BR | 1 |
| Lin, B | 1 |
| Phillips, AM | 1 |
| Haime, M | 1 |
| Quin, JA | 1 |
| Coletta, MJ | 1 |
| Lis, G | 1 |
| Clark, P | 1 |
| Dabir, R | 1 |
| Daneshvar, F | 1 |
| Arunachalam, K | 1 |
| Maan, A | 1 |
| Chu, A | 1 |
| Pong, T | 1 |
| Cyr, K | 1 |
| Niesen, J | 1 |
| Aparicio-Valenzuela, J | 1 |
| Carlton, C | 1 |
| Fischbein, MP | 1 |
| Woo, YJ | 1 |
| Boyd, JH | 1 |
| Lee, AM | 1 |
| Norhayati, MN | 1 |
| Shaiful Bahari, I | 1 |
| Zaharah, S | 1 |
| Nik Hazlina, NH | 1 |
| Mohammad Aimanazrul, Z | 1 |
| Irfan, M | 1 |
| Arvind, B | 1 |
| Kothari, SS | 1 |
| Juneja, R | 1 |
| Saxena, A | 1 |
| Ramakrishnan, S | 1 |
| Gupta, SK | 1 |
| Chowdhury, UK | 1 |
| Devagourou, V | 1 |
| Talwar, S | 1 |
| Hote, MP | 1 |
| Rajashekar, P | 1 |
| Sahu, MK | 1 |
| Singh, SP | 1 |
| Smith, HA | 1 |
| Kanji, S | 1 |
| Tran, DTT | 1 |
| Redpath, C | 1 |
| Ferguson, D | 1 |
| Lenet, T | 1 |
| Sigler, G | 1 |
| Gilbert, S | 1 |
| Maziak, D | 1 |
| Villeneuve, P | 1 |
| Sundaresan, S | 1 |
| Seely, AJE | 1 |
| Seto, AH | 1 |
| Abbott, NJ | 1 |
| Makkar, RR | 1 |
| Salazar, MA | 1 |
| Kolokotroni, SM | 1 |
| Toufektzian, L | 1 |
| Harling, L | 1 |
| Billè, A | 1 |
| Greenstein, D | 1 |
| Beau, J | 1 |
| Gottlieb, G | 1 |
| Teller, D | 1 |
| Kulik, A | 1 |
| Tzou, WS | 1 |
| Tung, R | 1 |
| Frankel, DS | 1 |
| Di Biase, L | 1 |
| Santangeli, P | 1 |
| Vaseghi, M | 1 |
| Bunch, TJ | 1 |
| Weiss, JP | 1 |
| Tholakanahalli, VN | 1 |
| Lakkireddy, D | 1 |
| Vunnam, R | 1 |
| Dickfeld, T | 1 |
| Mathuria, N | 1 |
| Tedrow, U | 1 |
| Vergara, P | 1 |
| Vakil, K | 1 |
| Nakahara, S | 1 |
| Burkhardt, JD | 1 |
| Stevenson, WG | 2 |
| Callans, DJ | 1 |
| Della Bella, P | 1 |
| Natale, A | 1 |
| Shivkumar, K | 1 |
| Marchlinski, FE | 1 |
| Sauer, WH | 1 |
| Entenmann, A | 1 |
| Michel, M | 1 |
| Herberg, U | 1 |
| Haas, N | 1 |
| Kumpf, M | 1 |
| Gass, M | 1 |
| Egender, F | 1 |
| Gebauer, R | 1 |
| Göndör, G | 1 |
| Stöllberger, C | 1 |
| Webster, G | 1 |
| Som, A | 1 |
| Sen, C | 1 |
| Goswami, A | 1 |
| Mehaffey, JH | 1 |
| Hawkins, RB | 1 |
| Byler, M | 1 |
| Smith, J | 1 |
| Kern, JA | 2 |
| Kron, I | 1 |
| Ailawadi, G | 2 |
| Wanchek, T | 1 |
| Yarboro, LT | 1 |
| Nicot, F | 1 |
| Procopi, N | 1 |
| Nguyen, LS | 1 |
| Fong, HK | 1 |
| Abdullah, O | 1 |
| Gautam, S | 1 |
| Brown, M | 1 |
| Nassoiy, S | 1 |
| Chaney, W | 1 |
| Plackett, TP | 1 |
| Blackwell, RH | 1 |
| Luchette, F | 1 |
| Engoren, M | 2 |
| Posluszny, J | 1 |
| Desai, CK | 1 |
| Bhatnagar, U | 1 |
| Stys, M | 1 |
| Schlesinger-Irsch, UR | 1 |
| Perlewitz, O | 1 |
| Nelles, M | 1 |
| Viskin, S | 1 |
| Chorin, E | 1 |
| Viskin, D | 1 |
| Hochstadt, A | 1 |
| Halkin, A | 1 |
| Tovia-Brodie, O | 1 |
| Lee, JK | 2 |
| Asher, E | 1 |
| Laish-Farkash, A | 1 |
| Amit, G | 1 |
| Havakuk, O | 1 |
| Belhassen, B | 1 |
| Rosso, R | 1 |
| Dobrev, D | 1 |
| Aguilar, M | 1 |
| Heijman, J | 1 |
| Guichard, JB | 1 |
| Nattel, S | 1 |
| Osmanovic, E | 1 |
| Ostojic, M | 1 |
| Avdic, S | 1 |
| Djedovic, S | 1 |
| Delic, A | 1 |
| Kadric, N | 1 |
| Terzic, A | 1 |
| Avdic-Salihovic, A | 1 |
| Atreya, AR | 1 |
| Priya, A | 1 |
| Pack, QR | 1 |
| Pekow, PS | 1 |
| Stefan, M | 1 |
| Lagu, T | 1 |
| Lotfi, AS | 1 |
| Lindenauer, PK | 1 |
| Skiba, MA | 1 |
| Pick, AW | 1 |
| Chaudhuri, K | 1 |
| Bailey, M | 1 |
| Krum, H | 1 |
| Kwa, LJ | 1 |
| Rosenfeldt, FL | 2 |
| Chatterjee, S | 1 |
| Sardar, P | 1 |
| Mukherjee, D | 1 |
| Lichstein, E | 2 |
| Aikat, S | 1 |
| Riber, LP | 2 |
| Christensen, TD | 4 |
| Pilegaard, HK | 2 |
| Plechev, VV | 1 |
| Zagidullin, ShZ | 1 |
| Iunusov, VM | 1 |
| Zubareva, IG | 1 |
| Nikolaeva, IE | 1 |
| Michel, C | 1 |
| Hecq, JD | 1 |
| Bertrand, C | 1 |
| Spinewine, A | 1 |
| Meerwein, C | 1 |
| Vital, D | 1 |
| Greutmann, M | 1 |
| Schmid, C | 1 |
| Huber, GF | 1 |
| Kato, Y | 1 |
| Beckerman, Z | 1 |
| Azran, A | 1 |
| Cohen, O | 1 |
| Nir, RR | 1 |
| Maessen, JG | 1 |
| Bianco-Peled, H | 1 |
| Bolotin, G | 1 |
| Osawa, H | 2 |
| Muraki, S | 1 |
| Sakurada, T | 2 |
| Kawaharada, N | 1 |
| Sasaki, J | 2 |
| Araki, E | 2 |
| Nakashima, S | 1 |
| Shea, J | 1 |
| Sodhi, G | 1 |
| Najam, F | 1 |
| Solomon, AJ | 3 |
| Cools, E | 1 |
| Missant, C | 1 |
| Berry, MF | 1 |
| D'Amico, TA | 1 |
| Onaitis, MW | 1 |
| Alados Arboledas, FJ | 1 |
| Millán-Miralles, L | 1 |
| Millán-Bueno, MP | 1 |
| Expósito-Montes, JF | 1 |
| Santiago-Gutierrez, C | 1 |
| Martínez Padilla, MC | 1 |
| Jennings, DL | 2 |
| Martinez, B | 1 |
| Montalvo, S | 1 |
| Lanfear, DE | 1 |
| Nebhani, T | 1 |
| Bakkali, H | 1 |
| Belyamani, L | 1 |
| Onk, OA | 1 |
| Erkut, B | 1 |
| Jackson, MW | 1 |
| Taylor, RJ | 1 |
| Shibata, SC | 1 |
| Uchiyama, A | 1 |
| Ohta, N | 1 |
| Fujino, Y | 1 |
| Zhang, L | 1 |
| Gao, S | 1 |
| Amrousy, DE | 1 |
| Elshehaby, W | 1 |
| Feky, WE | 1 |
| Elshmaa, NS | 1 |
| Habbab, LM | 1 |
| Chu, FV | 1 |
| Rivinius, R | 1 |
| Helmschrott, M | 1 |
| Ruhparwar, A | 1 |
| Schmack, B | 1 |
| Erbel, C | 1 |
| Gleissner, CA | 1 |
| Akhavanpoor, M | 1 |
| Frankenstein, L | 1 |
| Darche, FF | 1 |
| Schweizer, PA | 1 |
| Thomas, D | 1 |
| Ehlermann, P | 1 |
| Bruckner, T | 1 |
| Katus, HA | 1 |
| Doesch, AO | 1 |
| Gillinov, AM | 1 |
| Bagiella, E | 1 |
| Moskowitz, AJ | 1 |
| Raiten, JM | 1 |
| Groh, MA | 1 |
| Bowdish, ME | 1 |
| Kirkwood, KA | 1 |
| Perrault, LP | 1 |
| Parides, MK | 1 |
| Smith, RL | 1 |
| Dussault, G | 1 |
| Hackmann, AE | 1 |
| Jeffries, NO | 1 |
| Miller, MA | 1 |
| Taddei-Peters, WC | 1 |
| Rose, EA | 1 |
| Weisel, RD | 1 |
| Williams, DL | 1 |
| Mangusan, RF | 1 |
| Argenziano, M | 1 |
| Moquete, EG | 1 |
| O'Sullivan, KL | 1 |
| Pellerin, M | 1 |
| Shah, KJ | 1 |
| Gammie, JS | 1 |
| Mayer, ML | 1 |
| Voisine, P | 1 |
| Gelijns, AC | 1 |
| O'Gara, PT | 1 |
| Mack, MJ | 1 |
| Calkins, H | 3 |
| Ortega-Usobiaga, J | 1 |
| Llovet-Osuna, F | 1 |
| Reza Djodeyre, M | 1 |
| Cobo-Soriano, R | 1 |
| Llovet-Rausell, A | 1 |
| Baviera-Sabater, J | 1 |
| Chequel, M | 1 |
| Ollitrault, P | 1 |
| Saloux, E | 1 |
| Parienti, JJ | 1 |
| Fischer, MO | 1 |
| Desgué, J | 1 |
| Allouche, S | 1 |
| Milliez, P | 1 |
| Alexandre, J | 1 |
| Cooper, LB | 1 |
| Mentz, RJ | 1 |
| Edwards, LB | 1 |
| Wilk, AR | 1 |
| Rogers, JG | 1 |
| Patel, CB | 1 |
| Milano, CA | 1 |
| Hernandez, AF | 1 |
| Stehlik, J | 1 |
| Lund, LH | 1 |
| Lushaj, EB | 1 |
| Dhingra, R | 1 |
| Chindhy, S | 1 |
| Akhter, S | 1 |
| Kohmoto, T | 1 |
| Ulschmid, S | 1 |
| Osaki, S | 1 |
| Badami, A | 1 |
| Lozonschi, L | 1 |
| Teerakanok, J | 1 |
| Tantrachoti, P | 1 |
| Chariyawong, P | 1 |
| Nugent, K | 1 |
| Baker, WL | 1 |
| Men, EE | 1 |
| Yildirimtürk, O | 1 |
| Tuğcu, A | 1 |
| Aytekin, V | 1 |
| Aytekin, S | 1 |
| Kapoor, JR | 1 |
| Sleilaty, G | 1 |
| Madi-Jebara, S | 2 |
| Yazigi, A | 2 |
| Haddad, F | 2 |
| Hayeck, G | 1 |
| El Rassi, I | 1 |
| Ashoush, R | 1 |
| Jebara, V | 1 |
| Attaran, S | 1 |
| Sherwood, R | 1 |
| John, L | 1 |
| El-Gamel, A | 1 |
| Desai, J | 1 |
| Haas, NA | 2 |
| Camphausen, CK | 1 |
| Karacan, M | 1 |
| Olgun, H | 1 |
| Becit, N | 1 |
| Price, J | 1 |
| Tee, R | 1 |
| Lam, BK | 1 |
| Hendry, P | 1 |
| Green, MS | 1 |
| Rubens, FD | 1 |
| Kovacikova, L | 1 |
| Hakacova, N | 1 |
| Dobos, D | 1 |
| Skrak, P | 1 |
| Zahorec, M | 1 |
| Thomas, SP | 1 |
| Tisdale, JE | 3 |
| Wroblewski, HA | 2 |
| Wall, DS | 2 |
| Rieger, KM | 2 |
| Hammoud, ZT | 2 |
| Young, JV | 2 |
| Kesler, KA | 2 |
| Kojuri, J | 1 |
| Mahmoodi, Y | 1 |
| Jannati, M | 1 |
| Shafa, M | 1 |
| Ghazinoor, M | 1 |
| Sharifkazemi, MB | 1 |
| Beaulieu, Y | 1 |
| Denault, AY | 1 |
| Couture, P | 1 |
| Roy, D | 1 |
| Talajic, M | 1 |
| O'Meara, E | 1 |
| Carrier, M | 1 |
| Pagé, P | 1 |
| Levesque, S | 1 |
| Lambert, J | 1 |
| Tardif, JC | 1 |
| Uehara, K | 1 |
| Ueyama, K | 1 |
| Ito, H | 1 |
| Fukuda, T | 1 |
| Sasaki, K | 1 |
| Abe, T | 1 |
| Nakane, E | 1 |
| Miyamoto, S | 1 |
| Haruna, T | 1 |
| Inoko, M | 1 |
| Nohara, R | 1 |
| Rostagno, C | 1 |
| La Meir, M | 1 |
| Gelsomino, S | 1 |
| Ghilli, L | 1 |
| Rossi, A | 1 |
| Carone, E | 1 |
| Braconi, L | 1 |
| Rosso, G | 1 |
| Puggelli, F | 1 |
| Mattesini, A | 1 |
| Stefàno, PL | 1 |
| Padeletti, L | 1 |
| Maessen, J | 1 |
| Gensini, GF | 1 |
| Suzuki, S | 1 |
| Iwasaki, T | 1 |
| Morimatsu, H | 1 |
| Yokoi, N | 1 |
| Matsuoka, M | 1 |
| Suemori, T | 1 |
| Kanazawa, T | 1 |
| Shimizu, K | 1 |
| Toda, Y | 1 |
| Morita, K | 1 |
| Doniz Campos, M | 1 |
| Illodo Miramontes, G | 1 |
| Bobillo, B | 1 |
| Otero Amoedo, T | 1 |
| Filgueira, P | 1 |
| Rey López, F | 1 |
| Diz Gómez, JC | 1 |
| Franz, CC | 1 |
| Bruggisser, M | 1 |
| Krähenbühl, S | 2 |
| Rätz Bravo, AE | 2 |
| Lunati, M | 1 |
| Pedretti, S | 1 |
| Marchante, M | 1 |
| Ramos, F | 1 |
| Vicente, R | 1 |
| Navarro, JL | 1 |
| Barberá, M | 1 |
| Martínez-Comendador, J | 1 |
| Castaño, M | 1 |
| Mosquera, I | 1 |
| Plana, JG | 1 |
| Gualis, J | 1 |
| Martín, CE | 1 |
| Mencía, P | 1 |
| Imamura, M | 1 |
| Dossey, AM | 1 |
| Garcia, X | 1 |
| Shinkawa, T | 1 |
| Jaquiss, RD | 1 |
| Boriani, G | 1 |
| Ferruzzi, L | 1 |
| Corti, B | 1 |
| Ruffato, A | 1 |
| Gavelli, G | 1 |
| Mattioli, S | 1 |
| Ito, S | 1 |
| Konishi, T | 1 |
| Imazuru, T | 1 |
| Matsuzaki, K | 1 |
| Jikuya, T | 1 |
| Omae, T | 1 |
| Kanmura, Y | 1 |
| Viswam, D | 1 |
| Nair, SG | 1 |
| Patel, V | 1 |
| Modi, S | 1 |
| Foster, W | 1 |
| Todd, DM | 1 |
| Klein, GJ | 2 |
| Thiele, RH | 1 |
| Williams, J | 2 |
| Moylan, CA | 1 |
| Rao, SV | 1 |
| Bennett-Guerrero, E | 1 |
| Jensen, HK | 1 |
| Hoejsgaard, A | 1 |
| Pierret, C | 1 |
| Tourtier, JP | 1 |
| Pons, Y | 1 |
| Merat, S | 2 |
| Duverger, V | 1 |
| Perrier, E | 2 |
| Zhu, J | 1 |
| Wang, C | 1 |
| Gao, D | 1 |
| Zhang, C | 1 |
| Zhang, Y | 1 |
| Lu, Y | 1 |
| Gao, Y | 1 |
| Tomisti, L | 1 |
| Materazzi, G | 1 |
| Bartalena, L | 1 |
| Rossi, G | 1 |
| Marchello, A | 1 |
| Moretti, M | 1 |
| De Napoli, L | 1 |
| Mariotti, R | 1 |
| Miccoli, P | 1 |
| Martino, E | 1 |
| Bogazzi, F | 1 |
| Ohnishi, S | 1 |
| Mahoney, EM | 1 |
| Thompson, TD | 1 |
| Veledar, E | 1 |
| Weintraub, WS | 1 |
| Rahbani, P | 1 |
| Zeid, HA | 1 |
| Hayek, G | 1 |
| Hoffman, TM | 1 |
| Bush, DM | 1 |
| Wernovsky, G | 1 |
| Cohen, MI | 1 |
| Wieand, TS | 1 |
| Gaynor, JW | 1 |
| Spray, TL | 1 |
| Rhodes, LA | 1 |
| Lucet, V | 1 |
| Lanza, LA | 1 |
| Visbal, AI | 1 |
| DeValeria, PA | 1 |
| Zinsmeister, AR | 1 |
| Diehl, NN | 1 |
| Trastek, VF | 1 |
| Kogan, A | 1 |
| Ilgaev, N | 1 |
| Sahar, G | 1 |
| Kramer, M | 1 |
| Saute, M | 1 |
| Aravot, D | 1 |
| Berman, M | 1 |
| Vidne, BA | 1 |
| Zimmer, J | 1 |
| Pezzullo, J | 1 |
| Choucair, W | 1 |
| Southard, J | 1 |
| Kokkinos, P | 1 |
| Karasik, P | 1 |
| Greenberg, MD | 2 |
| Singh, SN | 1 |
| Drucker, MH | 1 |
| Smith, I | 1 |
| Saltman, AE | 2 |
| Yagdi, T | 1 |
| Nalbantgil, S | 1 |
| Ayik, F | 1 |
| Apaydin, A | 1 |
| Islamoglu, F | 1 |
| Posacioglu, H | 1 |
| Calkavur, T | 1 |
| Atay, Y | 1 |
| Buket, S | 1 |
| Cardona, F | 1 |
| Seide, H | 1 |
| Cox, RA | 1 |
| Pérez, CM | 1 |
| Hsieh, MH | 1 |
| Tai, CT | 1 |
| Tsai, CF | 1 |
| Lin, WS | 1 |
| Lin, YK | 1 |
| Tsao, HM | 1 |
| Huang, JL | 1 |
| Ueng, KC | 1 |
| Yu, WC | 1 |
| Chan, P | 1 |
| Ding, YA | 1 |
| Chang, MS | 1 |
| Chen, SA | 2 |
| Siccama, R | 1 |
| Balk, AH | 1 |
| de Herder, WW | 1 |
| van Domburg, R | 1 |
| Vantrimpont, P | 1 |
| van Gelder, T | 1 |
| Scherer, M | 1 |
| Dzemali, O | 1 |
| Aybek, T | 1 |
| Wimmer-Greinecker, G | 1 |
| Moritz, A | 1 |
| Kluger, J | 9 |
| White, CM | 10 |
| Krahn, AD | 1 |
| Yee, R | 1 |
| Zarnke, K | 1 |
| Simpson, C | 1 |
| Skanes, A | 1 |
| Crystal, E | 2 |
| Healey, J | 1 |
| Connolly, SJ | 1 |
| Burke, SW | 1 |
| Kuralay, E | 1 |
| Cingöz, F | 1 |
| Kiliç, S | 1 |
| Bolcal, C | 1 |
| Günay, C | 1 |
| Demirkiliç, U | 1 |
| Tatar, H | 1 |
| Blomberg, PJ | 1 |
| Feingold, AD | 1 |
| Denofrio, D | 1 |
| Rand, W | 1 |
| Konstam, MA | 1 |
| Estes, NA | 1 |
| Link, MS | 1 |
| Melo, J | 1 |
| Voigt, P | 1 |
| Sonmez, B | 1 |
| Ferreira, M | 1 |
| Abecasis, M | 1 |
| Rebocho, M | 1 |
| Timóteo, A | 1 |
| Aguiar, C | 1 |
| Tansal, S | 1 |
| Arbatli, H | 1 |
| Dion, R | 1 |
| Auer, J | 1 |
| Weber, T | 1 |
| Berent, R | 1 |
| Puschmann, R | 1 |
| Hartl, P | 1 |
| Ng, CK | 1 |
| Schwarz, C | 1 |
| Lehner, E | 1 |
| Strasser, U | 1 |
| Lassnig, E | 1 |
| Lamm, G | 1 |
| Eber, B | 1 |
| Kalus, JS | 3 |
| Caron, MF | 3 |
| Liu, X | 1 |
| Humphrey, C | 2 |
| Lambert, E | 1 |
| Lenoir, B | 1 |
| Bonnevie, L | 1 |
| Pats, B | 1 |
| Rostock, T | 1 |
| Willems, S | 1 |
| Ventura, R | 1 |
| Weiss, C | 1 |
| Risius, T | 1 |
| Meinertz, T | 2 |
| Nogami, A | 1 |
| Tada, H | 1 |
| Naito, S | 1 |
| Kaneko, T | 1 |
| Mayr, AJ | 1 |
| Dünser, MW | 1 |
| Ritsch, N | 1 |
| Pajk, W | 1 |
| Friesenecker, B | 1 |
| Knotzer, H | 1 |
| Ulmer, H | 1 |
| Wenzel, V | 1 |
| Hasibeder, WR | 1 |
| Bokhari, F | 1 |
| Newman, D | 1 |
| Greene, M | 1 |
| Korley, V | 1 |
| Mangat, I | 1 |
| Dorian, P | 1 |
| Reddy, P | 1 |
| Horowitz, S | 1 |
| Karapanos, A | 1 |
| Coleman, CI | 6 |
| Kerstein, J | 1 |
| Soodan, A | 1 |
| Qamar, M | 1 |
| Majid, M | 1 |
| Hollander, G | 1 |
| Shani, J | 1 |
| Mooss, AN | 2 |
| Wurdeman, RL | 2 |
| Sugimoto, JT | 1 |
| Packard, KA | 1 |
| Hilleman, DE | 3 |
| Lenz, TL | 2 |
| Rovang, KS | 1 |
| Arcidi, JM | 1 |
| Mohiuddin, SM | 3 |
| Mather, JF | 1 |
| Gallagher, R | 3 |
| Boden, WE | 1 |
| Canivet, JL | 1 |
| Yans, T | 1 |
| Roediger, L | 1 |
| Radermecker, MA | 1 |
| Lakhotia, R | 1 |
| Basvaraj, S | 1 |
| Kumar, M | 1 |
| Dubey, B | 1 |
| Mohanty, S | 1 |
| Kumar, R | 1 |
| Kabukcu, M | 1 |
| Yanik, E | 1 |
| Demircioglu, F | 1 |
| Gölbasi, I | 1 |
| Ersel, F | 1 |
| Samuels, LE | 1 |
| Holmes, EC | 1 |
| Samuels, FL | 1 |
| Lad, V | 1 |
| Drewe, J | 1 |
| Schlienger, RG | 1 |
| Pargger, H | 1 |
| Ummenhofer, W | 1 |
| Guglin, M | 1 |
| Nygård, E | 1 |
| Sørensen, LH | 1 |
| Hviid, LB | 1 |
| Pedersen, FM | 1 |
| Ravn, J | 1 |
| Thomassen, L | 1 |
| Svendsen, JH | 1 |
| Eliasen, K | 1 |
| Krogsgaard, K | 1 |
| Aldershvile, J | 1 |
| Sander, S | 4 |
| Perkerson, KA | 1 |
| Gillespie, EL | 4 |
| Takata, H | 2 |
| Kardas, M | 1 |
| Ismaili, A | 1 |
| Sedrakyan, A | 1 |
| Treasure, T | 1 |
| Browne, J | 1 |
| Krumholz, H | 1 |
| Sharpin, C | 1 |
| van der Meulen, J | 1 |
| Kocheril, AG | 1 |
| Sharma, AD | 1 |
| Cher, D | 1 |
| Stubbs, HA | 1 |
| Block, JE | 1 |
| Gryskiewicz, KA | 1 |
| Fox, S | 1 |
| Skinner, JR | 1 |
| Frangini, P | 1 |
| Vergara, I | 1 |
| Fajuri, A | 1 |
| González, R | 1 |
| Baeza, M | 1 |
| Shingu, Y | 1 |
| Aoki, H | 1 |
| Oba, J | 1 |
| Takigami, K | 1 |
| Eya, K | 1 |
| Ebuoka, N | 1 |
| Stippel, DL | 1 |
| Taylan, C | 1 |
| Schröder, W | 1 |
| Beckurts, KT | 1 |
| Hölscher, AH | 1 |
| Abreu Filho, CA | 1 |
| Lisboa, LA | 1 |
| Dallan, LA | 1 |
| Spina, GS | 1 |
| Grinberg, M | 1 |
| Scanavacca, M | 1 |
| Sosa, EA | 1 |
| Ramires, JA | 1 |
| Oliveira, SA | 1 |
| Ho, AM | 1 |
| Karmakar, MK | 1 |
| Hunter, CB | 1 |
| Maciejewski, S | 1 |
| Venkatesan, T | 1 |
| Ninan, S | 1 |
| Jung, W | 1 |
| Meyerfeldt, U | 1 |
| Birkemeyer, R | 1 |
| Patel, AA | 1 |
| Budeus, M | 1 |
| Hennersdorf, M | 1 |
| Perings, S | 1 |
| Röhlen, S | 1 |
| Schnitzler, S | 1 |
| Felix, O | 1 |
| Reimert, K | 1 |
| Feindt, P | 1 |
| Gams, E | 1 |
| Lehmann, N | 1 |
| Wieneke, H | 1 |
| Sack, S | 1 |
| Erbel, R | 1 |
| Perings, C | 1 |
| Serón, D | 1 |
| Hagège, AA | 1 |
| Marolleau, JP | 1 |
| Vilquin, JT | 1 |
| Alhéritière, A | 1 |
| Peyrard, S | 1 |
| Duboc, D | 1 |
| Abergel, E | 1 |
| Messas, E | 1 |
| Mousseaux, E | 1 |
| Schwartz, K | 1 |
| Desnos, M | 1 |
| Menasché, P | 2 |
| Shantsila, E | 1 |
| Watson, T | 1 |
| Lip, GY | 1 |
| Riera, M | 1 |
| Herrero, J | 1 |
| Antón, E | 1 |
| Fiol, M | 1 |
| Carrió, ML | 1 |
| Fortià, C | 1 |
| Javierre, C | 1 |
| Rodríguez, D | 1 |
| Farrero, E | 1 |
| Castells, E | 1 |
| Ventura, JL | 1 |
| Henyan, N | 2 |
| Minhaj, MM | 1 |
| Zvara, DA | 1 |
| Nayyar, P | 1 |
| Maslow, A | 1 |
| Buckley, MS | 1 |
| Nolan, PE | 1 |
| Slack, MK | 1 |
| Copeland, JG | 1 |
| Zebis, LR | 2 |
| Thomsen, HF | 1 |
| Mikkelsen, MM | 1 |
| Folkersen, L | 1 |
| Sørensen, HT | 1 |
| Hjortdal, VE | 2 |
| Tapio, H | 1 |
| Jari, H | 1 |
| Kimmo, M | 1 |
| Juha, H | 1 |
| Tempe, DK | 1 |
| Gandhi, A | 1 |
| Mehta, V | 1 |
| Banerjee, A | 1 |
| Datt, V | 1 |
| Ramamurthy, P | 1 |
| Goyal, G | 1 |
| Rankin, JS | 1 |
| Turk, T | 1 |
| Ata, Y | 1 |
| Vural, H | 1 |
| Ozkan, H | 1 |
| Yavuz, S | 1 |
| Ozyazicioglu, A | 1 |
| Iwamoto, J | 1 |
| Inoue, H | 1 |
| Alves, RJ | 1 |
| Geovanini, GR | 1 |
| Brito, Gd | 1 |
| Miguel, GA | 1 |
| Glauser, VA | 1 |
| Nakiri, K | 1 |
| Khanderia, U | 1 |
| Wagner, D | 1 |
| Walker, PC | 1 |
| Woodcock, B | 1 |
| Prager, R | 1 |
| Dale, K | 1 |
| Reinhart, K | 1 |
| Turner, S | 1 |
| Mathews, L | 1 |
| Pandharipande, P | 1 |
| Thompson, R | 1 |
| Kristiansen, IS | 1 |
| Berdajs, D | 1 |
| Schurr, UP | 1 |
| Wagner, A | 1 |
| Seifert, B | 1 |
| Turina, MI | 1 |
| Genoni, M | 1 |
| Rajatanavin, R | 1 |
| Safran, M | 1 |
| Stoller, WA | 1 |
| Mordes, JP | 1 |
| Braverman, LE | 1 |
| Vitale, P | 1 |
| Agretto, A | 1 |
| Torre, G | 1 |
| Casale, D | 1 |
| Porreca, GP | 1 |
| Jacono, A | 1 |
| Installe, E | 1 |
| Schoevaerdts, JC | 1 |
| Gadisseux, P | 1 |
| Charles, S | 1 |
| Tremouroux, J | 1 |
| Terada, Y | 2 |
| Mitsui, T | 2 |
| Yoshimura, Y | 1 |
| Osaka, M | 1 |
| Mihara, W | 1 |
| Heric, B | 1 |
| Lytle, BW | 1 |
| Miller, DP | 1 |
| Rosenkranz, ER | 1 |
| Lever, HM | 1 |
| Cosgrove, DM | 1 |
| van der Zeijden, H | 1 |
| Zandstra, DF | 1 |
| Rose, EP | 1 |
| Alves, LE | 1 |
| Mickleborough, LL | 1 |
| Maruyama, H | 1 |
| Mohamed, S | 1 |
| Rappaport, DC | 1 |
| Downar, E | 1 |
| Butany, J | 1 |
| Sun, Z | 1 |
| Yamaguchi, I | 1 |
| Raja, P | 1 |
| Hawker, RE | 1 |
| Chaikitpinyo, A | 1 |
| Cooper, SG | 1 |
| Lau, KC | 1 |
| Nunn, GR | 1 |
| Cartmill, TB | 1 |
| Sholler, GF | 1 |
| Cochrane, AD | 1 |
| Siddins, M | 1 |
| Salamonsen, R | 1 |
| McConaghy, L | 1 |
| Marasco, S | 1 |
| Davis, BB | 1 |
| Butler, J | 1 |
| Harriss, DR | 1 |
| Sinclair, M | 1 |
| Westaby, S | 1 |
| Mathru, M | 1 |
| McDaniel, LB | 1 |
| Van Mieghem, W | 2 |
| Coolen, L | 1 |
| Malysse, I | 1 |
| Lacquet, LM | 1 |
| Deneffe, GJ | 1 |
| Demedts, MG | 1 |
| Rogers, NK | 1 |
| Bowen, DI | 1 |
| Noble, BA | 1 |
| Mulligan, DC | 1 |
| McHenry, CR | 2 |
| Kinney, W | 1 |
| Esselstyn, CB | 1 |
| Di Biasi, P | 1 |
| Scrofani, R | 1 |
| Paje, A | 1 |
| Cappiello, E | 1 |
| Mangini, A | 1 |
| Santoli, C | 1 |
| Tits, G | 1 |
| Demuynck, K | 1 |
| Lacquet, L | 1 |
| Deneffe, G | 1 |
| Tjandra-Maga, T | 1 |
| Demedts, M | 1 |
| Vaksmann, G | 1 |
| Lacroix, D | 1 |
| Klug, D | 1 |
| Villain, E | 2 |
| Bonnet, D | 1 |
| Iserin, L | 1 |
| Aggoun, Y | 1 |
| Sidi, D | 1 |
| Kachaner, J | 1 |
| Bahu, M | 1 |
| Shyr, Y | 1 |
| Schork, A | 1 |
| Bolling, S | 1 |
| Kou, W | 1 |
| Kirsch, M | 1 |
| Morady, F | 3 |
| Nanas, JN | 1 |
| Anastasiou-Nana, MI | 1 |
| Margari, ZJ | 1 |
| Karli, J | 1 |
| Moulopoulos, SD | 1 |
| Dimopoulou, I | 1 |
| Marathias, K | 1 |
| Daganou, M | 1 |
| Prapas, S | 1 |
| Stavridis, G | 1 |
| Khoury, M | 1 |
| Geroulanos, S | 1 |
| Cokkinos, DV | 1 |
| Rady, MY | 1 |
| Ryan, T | 1 |
| Starr, NJ | 1 |
| Daoud, EG | 1 |
| Strickberger, SA | 1 |
| Man, KC | 1 |
| Goyal, R | 1 |
| Deeb, GM | 1 |
| Bolling, SF | 1 |
| Pagani, FD | 1 |
| Bitar, C | 1 |
| Meissner, MD | 1 |
| McCullough, PA | 1 |
| Redle, JD | 1 |
| Zaman, AG | 1 |
| Archbold, A | 1 |
| Alamgir, F | 1 |
| Ulahannan, TJ | 1 |
| Myles, PS | 1 |
| Guaragna, JC | 1 |
| Martins, V | 1 |
| Brunini, TM | 1 |
| Linhatti, JL | 1 |
| Brauner, FB | 1 |
| Pires, RC | 1 |
| Bodanese, LC | 1 |
| Douchet, MP | 1 |
| Barsotti, P | 1 |
| Schneeberger, M | 1 |
| Bauer, C | 1 |
| Massard, G | 1 |
| Brechenmacher, C | 1 |
| Wihlm, JM | 1 |
| Humphries, JO | 1 |
| Sousa, J | 2 |
| Rocha, V | 2 |
| Silvestre, I | 2 |
| Pereira, EV | 2 |
| Alacatrão, M | 1 |
| Ferreira, FF | 2 |
| Raposo, F | 2 |
| Alcatrão, M | 1 |
| Katai, N | 1 |
| Yokoyama, R | 1 |
| Yoshimura, N | 1 |
| Guarnieri, T | 1 |
| Katariya, K | 1 |
| DeMarchena, E | 1 |
| Bolooki, H | 1 |
| Ciriaco, P | 1 |
| Mazzone, P | 1 |
| Canneto, B | 1 |
| Zannini, P | 1 |
| Dörge, H | 1 |
| Schoendube, FA | 1 |
| Schoberer, M | 1 |
| Stellbrink, C | 1 |
| Voss, M | 1 |
| Messmer, BJ | 1 |
| Lee, SH | 1 |
| Chang, CM | 1 |
| Lu, MJ | 1 |
| Lee, RJ | 1 |
| Cheng, JJ | 1 |
| Hung, CR | 1 |
| Cioffi, G | 1 |
| Cemin, C | 1 |
| Russo, TE | 1 |
| Pellegrini, A | 1 |
| Terrasi, F | 1 |
| Ferrario, G | 1 |
| Treggiari-Venzi, MM | 1 |
| Waeber, JL | 1 |
| Perneger, TV | 1 |
| Suter, PM | 1 |
| Adamec, R | 1 |
| Romand, JA | 1 |
| Mittendorf, EA | 1 |
| Stiefelhagen, P | 1 |
| Bharat, V | 1 |
| Mohanty, B | 1 |
| Sloan, SB | 1 |
| Weitz, HH | 1 |
| Harahsheh, BS | 1 |
| Sawalha, WA | 1 |
| Kilborn, MJ | 1 |
| Katz, NM | 1 |
| Stamou, SC | 1 |
| Hill, PC | 1 |
| Sample, GA | 1 |
| Snider, E | 1 |
| Pfister, AJ | 1 |
| Lowery, RC | 1 |
| Corso, PJ | 1 |
| Dodge-Khatami, A | 1 |
| Miller, OI | 1 |
| Anderson, RH | 1 |
| Gil-Jaurena, JM | 1 |
| Goldman, AP | 1 |
| de Leval, MR | 1 |
| Tokmakoglu, H | 1 |
| Kandemir, O | 1 |
| Gunaydin, S | 1 |
| Catav, Z | 1 |
| Yorgancioglu, C | 1 |
| Zorlutuna, Y | 1 |
| Haan, CK | 1 |
| Geraci, SA | 1 |
| Cabrera Duro, A | 1 |
| Rodrigo Carbonero, D | 1 |
| Galdeano Miranda, JM | 1 |
| Martínez Corrales, P | 1 |
| Pastor Menchaca, E | 1 |
| Macua Biurrun, P | 1 |
| Pilar Orive, J | 1 |
| Michat, L | 1 |
| Cabrol, C | 1 |
| Mattei, MF | 1 |
| Gobin, F | 1 |
| Bourel, LM | 1 |
| Grandjbakhch, I | 1 |
| Guiraudon, G | 1 |
| Chelimsky-Fallick, C | 1 |
| Middlekauff, HR | 1 |
| Kobashigawa, J | 1 |
| Saxon, LA | 1 |
| Moriguchi, J | 1 |
| Brownfield, ED | 1 |
| Hamilton, MA | 1 |
| Drinkwater, D | 1 |
| Laks, H | 1 |
| Konertz, W | 1 |
| Weyand, M | 1 |
| Deiwick, M | 1 |
| Scheld, HH | 1 |
| Bach, P | 1 |
| Gonschior, P | 1 |
| Prinz, C | 1 |
| Kreuzer, E | 1 |
| Autenrieth, G | 1 |
| Steinbeck, G | 1 |
| Saussine, M | 1 |
| Colson, P | 1 |
| Alauzen, M | 1 |
| Mary, H | 1 |
| Greene, CA | 1 |
| Case, CL | 1 |
| Gillette, PC | 1 |
| Greenspon, AJ | 1 |
| Kidwell, GA | 1 |
| Hurley, W | 1 |
| Mannion, J | 1 |
| Hohnloser, SH | 1 |
| Dammbacher, T | 1 |
| Steiert, K | 1 |
| Jähnchen, E | 1 |
| Zehender, M | 1 |
| Fraedrich, G | 1 |
| Just, H | 1 |
| Frilling, A | 1 |
| Goretzki, PE | 1 |
| Röher, HD | 1 |
| Kupferschmid, JP | 1 |
| Rosengart, TK | 1 |
| McIntosh, CL | 1 |
| Leon, MB | 1 |
| Clark, RE | 1 |
| Kelly, PA | 1 |
| Cannom, DS | 1 |
| Garan, H | 1 |
| Mirabal, GS | 1 |
| Harthorne, JW | 1 |
| Hurvitz, RJ | 1 |
| Vlahakes, GJ | 1 |
| Jacobs, ML | 1 |
| Ilvento, JP | 1 |
| Buckley, MJ | 1 |
| Kay, GN | 1 |
| Epstein, AE | 1 |
| Kirklin, JK | 1 |
| Diethelm, AG | 1 |
| Graybar, G | 1 |
| Plumb, VJ | 1 |
| Nalos, PC | 1 |
| Kass, RM | 1 |
| Gang, ES | 1 |
| Fishbein, MC | 1 |
| Mandel, WJ | 1 |
| Peter, T | 1 |
| Huang, ZD | 1 |
| Deng, HF | 1 |
| Zhang, BX | 1 |
| George, M | 1 |
| Villard, J | 1 |
| Bastien, O | 1 |
| Hercule, C | 1 |
| Lehot, JJ | 1 |
| Nicolai, Y | 1 |
| Gensous, D | 1 |
| Estanove, S | 1 |
| Escoubet, B | 1 |
| Jaillon, P | 1 |
| Berger, Y | 1 |
| Commin, P | 1 |
| Piwnica, A | 1 |
| Echter, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Assessment of Intra-Operative Atrial Fibrillation Inducibility As a Screening Tool to Prevent Post-Operative Atrial Fibrillation With Prophylaxis Amiodarone[NCT03868150] | Phase 4 | 600 participants (Anticipated) | Interventional | 2017-03-01 | Recruiting | ||
| Prophylaxis for Patients at Risk to Eliminate Post-operative Atrial Fibrillation[NCT04392921] | 80 participants (Anticipated) | Interventional | 2022-03-07 | Recruiting | |||
| Modeling of Amiodarone Effect on Heart Rate Control in Critically Ill Patients With Atrial Tachyarrhythmias[NCT03413150] | 80 participants (Actual) | Observational | 2007-01-31 | Completed | |||
| Association of Postoperative Lactate Levels With Postoperative Atrial Fibrillation in Patients Undergoing Isolated Coronary Artery Bypass Graft Surgery[NCT05448521] | 250 participants (Anticipated) | Observational | 2022-08-15 | Recruiting | |||
| Statin Therapy With Atorvastatin in Surgical Aortic Valve Replacement - a Randomized Controlled Trial[NCT05076019] | 266 participants (Anticipated) | Interventional | 2022-02-01 | Recruiting | |||
| Post-Operative Atrial Fibrillation After Surgical Aortic Valve Replacement and the Influence of Statins - Randomized Controlled Trial[NCT05062239] | 100 participants (Anticipated) | Interventional | 2022-04-01 | Recruiting | |||
| A Pharmaco-surgical Approach to Reduce Postoperative Atrial Fibrillation After Cardiac Surgery[NCT05780320] | 242 participants (Anticipated) | Observational | 2022-09-19 | Active, not recruiting | |||
| Pragmatic Amiodarone Trial to Reduce Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery[NCT05543278] | Phase 4 | 242 participants (Anticipated) | Interventional | 2023-12-01 | Not yet recruiting | ||
| Multicenter Study for the Prevention of Post-Operative Cardiac Arrhythmias[NCT04234906] | Phase 4 | 870 participants (Anticipated) | Interventional | 2023-01-31 | Not yet recruiting | ||
| A Prospective Study Using Intra-Pericardial Amiodarone for the Prevention of Postoperative Atrial Fibrillation (POAF) in Patients Undergoing Cardiac Arterial Bypass Grafting and/or Valve Surgery[NCT06063538] | Early Phase 1 | 63 participants (Anticipated) | Interventional | 2023-11-30 | Not yet recruiting | ||
| A Prospective Pilot Study of the Combination of CardiaMend and Amiodarone for the Prevention of Postoperative Atrial Fibrillation (POAF) in Patients Undergoing Isolated Cardiac Arterial Bypass Grafting or Isolated Valve Surgery (CAMP POAF)[NCT05681182] | Phase 4 | 30 participants (Anticipated) | Interventional | 2023-01-20 | Recruiting | ||
| Trial of New Oral Anticoagulants vs. Warfarin for Post Cardiac Surgery Atrial Fibrillation[NCT03702582] | Phase 3 | 100 participants (Actual) | Interventional | 2019-04-30 | Completed | ||
| Rate Control Versus Rhythm Control For Postoperative Atrial Fibrillation[NCT02132767] | Phase 3 | 523 participants (Actual) | Interventional | 2014-05-31 | Completed | ||
| Prevention of Atrial Fibrillation Following Noncardiac Thoracic Surgery[NCT00127712] | Phase 4 | 130 participants (Actual) | Interventional | 2004-09-30 | Completed | ||
| Effect of Prophylaxy of Amiodarone and Propranolol and Amiodarone With Propranolol in Prevention of Atrial Fibrillation Post Coronary Artery Bypass Graft, A Prospective Double-Blind Randomized Study[NCT00654290] | 240 participants (Actual) | Interventional | 2007-03-31 | Completed | |||
| Apixaban Versus Warfarin for the Management of Post-operative Atrial Fibrillation: a Prospective, Controlled, Randomized Pilot Study[NCT02889562] | Phase 2/Phase 3 | 56 participants (Actual) | Interventional | 2016-09-30 | Completed | ||
| A Randomized Controlled Trial of Prophylactic Pulmonary Vein Isolation as Adjunct to Coronary Artery Bypass Grafting[NCT00338715] | Phase 3 | 193 participants (Actual) | Interventional | 2006-07-31 | Completed | ||
| Effect of Venous Cannulation Technique on the Incidence of Post-operative Atrial Fibrillation in Patients Undergoing Elective Coronary Artery Bypass Grafting. A Pilot Randomized Controlled Trial.[NCT04641611] | 40 participants (Anticipated) | Interventional | 2022-07-01 | Recruiting | |||
| Tailored Treatment of Permanent Atrial Fibrillation - TTOP-AF[NCT00514735] | Phase 3 | 210 participants (Actual) | Interventional | 2007-05-31 | Completed | ||
| A Randomized Prospective Comparison of DDD Chamber Pacing and Percutaneous Transluminal Septal Ablation in Obstructive Hypertrophic Cardiomyopathy Associated With Severe Drug-Refractory Symptoms[NCT00001894] | Phase 2 | 70 participants | Interventional | 1999-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Compare heart rhythm (number of patients in sustained, stable non-AF rhythm) between treatment arms at 60 days after randomization (NCT02132767)
Timeframe: 60 days after randomization
| Intervention | participants (Number) |
|---|---|
| Rate Control | 220 |
| Rhythm Control | 231 |
Compare heart rhythm (number of patients in sustained, stable non-AF rhythm) between treatment arms at hospital discharge (NCT02132767)
Timeframe: Hospital discharge
| Intervention | participants (Number) |
|---|---|
| Rate Control | 231 |
| Rhythm Control | 244 |
Compare heart rhythm (patients in sustained, stable non-AF rhythm) between treatment arms at 30 days after randomization (NCT02132767)
Timeframe: 30 days after randomization
| Intervention | participants (Number) |
|---|---|
| Rate Control | 220 |
| Rhythm Control | 223 |
Overall length of stay for the index hospitalization (NCT02132767)
Timeframe: Within 60 days post surgery
| Intervention | days (Median) |
|---|---|
| Rate Control | 4.3 |
| Rhythm Control | 4.3 |
Compare length of stay between groups for any cause and AF-related hospitalizations, including ED visits (NCT02132767)
Timeframe: Within 60 days of randomization
| Intervention | days (Median) |
|---|---|
| Rate Control | 2.2 |
| Rhythm Control | 2.1 |
Compare frequency of outpatient visits between groups for any cause and AF-related causes (NCT02132767)
Timeframe: Within 60 days of randomization
| Intervention | hospital stays < 24 hours (Number) |
|---|---|
| Rate Control | 5 |
| Rhythm Control | 4 |
(NCT02132767)
Timeframe: Up to index hospital discharge or 7 days post surgery, whichever came first
| Intervention | days (Median) |
|---|---|
| Rate Control | 1.85 |
| Rhythm Control | 0.95 |
The total number of days in hospital for any hospitalization that occurs within 60 days of randomization to AF treatment strategy. (NCT02132767)
Timeframe: Within 60 days of randomization
| Intervention | days (Median) |
|---|---|
| Rate Control | 5.1 |
| Rhythm Control | 5.0 |
(NCT00127712)
Timeframe: 7 days
| Intervention | Participants (Number) |
|---|---|
| Amiodarone | 9 |
| Control | 22 |
(NCT00127712)
Timeframe: 7 days
| Intervention | participants (Number) |
|---|---|
| Amiodarone | 9 |
| Control | 21 |
(NCT00127712)
Timeframe: Duration of hospitalization
| Intervention | Days (Median) |
|---|---|
| Amiodarone | 7 |
| Control | 8 |
(NCT00127712)
Timeframe: Duration of hospitalization
| Intervention | Hours (Median) |
|---|---|
| Amiodarone | 46 |
| Control | 84 |
Efficacy will be measured by the freedom from stroke during the study period. Events relating to stroke will be adjudicated using pre-determined definitions by independent committee members that remain blinded to the patient's treatment arm. (NCT02889562)
Timeframe: 30 days
| Intervention | participants (Number) |
|---|---|
| Apixaban | 0 |
| Warfarin | 0 |
Efficacy will be measured by the freedom from thromboembolytic events during the study period. Events relating to thromboembolytic events will be adjudicated using pre-determined definitions by independent committee members that remain blinded to the patient's treatment arm. (NCT02889562)
Timeframe: 30 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Apixaban | 0 |
| Warfarin | 0 |
Time in therapeutic range of INR, if on warfarin, (eg. 2-3), measured as a percentage and defined for each patient using the Rosendaal equation (NCT02889562)
Timeframe: 30 days
| Intervention | percentage (Mean) |
|---|---|
| Warfarin | 56.8 |
This will be measured from the date/time of the end of the subject's surgery until the date/time of the patient's discharge from the hospital. This will be measured in hours, to the nearest tenth of an hour. (NCT02889562)
Timeframe: 30 days
| Intervention | hours (Mean) |
|---|---|
| Apixaban | 167.5 |
| Warfarin | 143.1 |
Units of blood or blood products given after the first dose of anticoagulation. (NCT02889562)
Timeframe: 30 days
| Intervention | total units of blood (Number) |
|---|---|
| Apixaban | 6 |
| Warfarin | 2 |
"A treatment success/failure up to the conclusion of the procedure for each subject in Ablation Management. A subject was considered successfully treated if the following were true:~Medtronic ablation catheters were used to achieve procedure success.~All accessible pulmonary veins were isolated.~At least 50% reduction of complex fractionated atrial electrograms mapped and ablated with Medtronic ablation catheters.~Sinus rhythm was achieved upon leaving the electrophysiology lab (±cardioversion)." (NCT00514735)
Timeframe: Procedure conclusion
| Intervention | percentage of participants (Mean) |
|---|---|
| Ablation Management | 92.8 |
The primary endpoint for acute safety was a success/failure variable calculated for each subject in Ablation Management at the 7 day post-procedure time point. Any subject with at least one adverse event adjudicated by the Data Safety Monitoring Board as both serious and either probably or definitely procedure and/or device-related occurring within 7 days of the ablation procedure was considered an acute safety failure, regardless of whether the event occurred following the index or retreatment ablation procedure. (NCT00514735)
Timeframe: 7 days
| Intervention | percentage of participants (Mean) |
|---|---|
| Ablation Management | 12.3 |
"The chronic efficacy endpoint was a treatment success/failure measure for each subject computed at 6 months. Treatment success included:~A 90% reduction in clinically significant atrial fibrillation from baseline to the 6 month time point based on a Holter recording. Clinically significant atrial fibrillation was defined as sustained atrial fibrillation lasting more than 10 minutes.~The subject was off all antiarrhythmic drugs at 6 months (Ablation Management arm only)~The Investigator judged all procedures to be acutely successful (Ablation Management arm only)." (NCT00514735)
Timeframe: 6 months
| Intervention | percentage of participants with success (Number) |
|---|---|
| Ablation Management | 56 |
| Medical Management | 26 |
The primary endpoint for chronic safety was a success/failure variable calculated for each subject at 6 months. Any subject that had at least one adverse event that met designated seriousness and relatedness criteria for the particular treatment group as adjudicated by the Data Safety Monitoring Board was considered a chronic safety failure. Adverse events in Ablation Management that were acute (≤7 days) were not included in the chronic safety primary endpoint. Given the disparity in the length of time at risk between treatment arms,the Chronic Safety endpoint was not statistically powered. (NCT00514735)
Timeframe: 6 months
| Intervention | participants (Number) |
|---|---|
| Ablation Management | 9 |
| Medical Management | 3 |
The SF-36 questionnaire was administered to subjects at baseline, 1, 3 and 6 month visits. The SF-36 is a multi-purpose, short-form health survey with only 36 questions. It yields an 8-scale profile of functional health and well-being scores as well as psychometrically-based Physical Component Score and Mental Component Score. The possible range for Physical Component Score and Mental Component Score is 0 to 100. The higher score, the better quality of life. (NCT00514735)
Timeframe: 6 months
| Intervention | Scores on a scale (Mean) | |||||||
|---|---|---|---|---|---|---|---|---|
| Physical Component Score at Baseline | Physical Component Score at 1 Month | Physical Component Score at 3 Months | Physical Component Score at 6 Months | Mental Component Score at Baseline | Mental Component Score at 1 Month | Mental Component Score at 3 Months | Mental Component Score at 6 Months | |
| Ablation Management | 42.54 | 45.61 | 48.30 | 49.12 | 47.19 | 51.53 | 53.42 | 53.45 |
| Medical Management | 42.26 | 43.05 | 43.99 | 44.98 | 47.99 | 48.96 | 48.97 | 50.06 |
The severity of subject's atrial fibrillation related symptoms on a scale from 1 (no symptoms) to 5 (most severe). The symptoms included palpitations, fatigue, shortness of breath, lightheadedness or dizziness, and lack of energy during exertion or exercise. The scores were tabulated at the 1, 3 and 6 month follow-up visits. Scores could range from 5 to 25, indicating a spectrum of subject status from asymptomatic to severely symptomatic. (NCT00514735)
Timeframe: 6 months
| Intervention | AF Symptom Severity Score (Mean) | |||
|---|---|---|---|---|
| Measurement at Baseline | Measurement at 1 Month | Measurement at 3 Months | Measurement at 6 Months | |
| Ablation Management | 12.38 | 8.95 | 7.56 | 7.58 |
| Medical Management | 12.72 | 9.90 | 10.03 | 9.84 |
Left atrial diameter (LAD), as measured by transthoracic echocardiogram (TTE) looking at the longitudinal long axis at baseline and at the 6 month follow-up visit in both the Ablation and Medical Management arms. (NCT00514735)
Timeframe: 6 months
| Intervention | centimeters (Mean) | |
|---|---|---|
| Measurement at Baseline | Measurement at 6 Months | |
| Ablation Management | 4.5 | 4.4 |
| Medical Management | 4.6 | 4.6 |
Left ventricular ejection fraction (LVEF), as measured by transthoracic echocardiogram at baseline and 6 months in both the Ablation and Medical Management arms. (NCT00514735)
Timeframe: 6 months
| Intervention | percent (Mean) | |
|---|---|---|
| Measurement at Baseline | Measurement at 6 Months | |
| Ablation Management | 54.7 | 58.3 |
| Medical Management | 54.9 | 57.0 |
44 reviews available for amiodarone and Postoperative Complications
| Article | Year |
|---|---|
Effectiveness of intra-operative topical amiodarone for prevention of postcardiac surgery new-onset atrial fibrillation: A review of current evidence.
Topics: Amiodarone; Atrial Fibrillation; Cardiac Surgical Procedures; Humans; Postoperative Complications | 2022 |
Effectiveness of intra-operative topical amiodarone for prevention of postcardiac surgery new-onset atrial fibrillation: A review of current evidence.
Topics: Amiodarone; Atrial Fibrillation; Cardiac Surgical Procedures; Humans; Postoperative Complications | 2022 |
Effectiveness of intra-operative topical amiodarone for prevention of postcardiac surgery new-onset atrial fibrillation: A review of current evidence.
Topics: Amiodarone; Atrial Fibrillation; Cardiac Surgical Procedures; Humans; Postoperative Complications | 2022 |
Effectiveness of intra-operative topical amiodarone for prevention of postcardiac surgery new-onset atrial fibrillation: A review of current evidence.
Topics: Amiodarone; Atrial Fibrillation; Cardiac Surgical Procedures; Humans; Postoperative Complications | 2022 |
Effectiveness of intra-operative topical amiodarone for prevention of postcardiac surgery new-onset atrial fibrillation: A review of current evidence.
Topics: Amiodarone; Atrial Fibrillation; Cardiac Surgical Procedures; Humans; Postoperative Complications | 2022 |
Effectiveness of intra-operative topical amiodarone for prevention of postcardiac surgery new-onset atrial fibrillation: A review of current evidence.
Topics: Amiodarone; Atrial Fibrillation; Cardiac Surgical Procedures; Humans; Postoperative Complications | 2022 |
Effectiveness of intra-operative topical amiodarone for prevention of postcardiac surgery new-onset atrial fibrillation: A review of current evidence.
Topics: Amiodarone; Atrial Fibrillation; Cardiac Surgical Procedures; Humans; Postoperative Complications | 2022 |
Effectiveness of intra-operative topical amiodarone for prevention of postcardiac surgery new-onset atrial fibrillation: A review of current evidence.
Topics: Amiodarone; Atrial Fibrillation; Cardiac Surgical Procedures; Humans; Postoperative Complications | 2022 |
Effectiveness of intra-operative topical amiodarone for prevention of postcardiac surgery new-onset atrial fibrillation: A review of current evidence.
Topics: Amiodarone; Atrial Fibrillation; Cardiac Surgical Procedures; Humans; Postoperative Complications | 2022 |
Atrial Fibrillation in Hypertrophic Cardiomyopathy: Evidence-based Review About Mechanism, Complications and Management.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiomyopathy | 2020 |
Metoprolol for prophylaxis of postoperative atrial fibrillation in cardiac surgery patients: systematic review and meta-analysis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Humans; Metopr | 2020 |
In patients undergoing lung resection is it safe to administer amiodarone either as prophylaxis or treatment of atrial fibrillation?
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Lung Diseases; Pneumonectomy; | 2017 |
Amiodarone Refractory Electrical Storm Post-Revascularization for Anterior ST Elevation Myocardial Infarction: A Case Report and Brief Review of the Literature.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Catheter Ablation; Drug Resistance; Humans | 2018 |
Postoperative atrial fibrillation: mechanisms, manifestations and management.
Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Calci | 2019 |
Postoperative atrial fibrillation: mechanisms, manifestations and management.
Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Calci | 2019 |
Postoperative atrial fibrillation: mechanisms, manifestations and management.
Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Calci | 2019 |
Postoperative atrial fibrillation: mechanisms, manifestations and management.
Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Calci | 2019 |
Postoperative atrial fibrillation: mechanisms, manifestations and management.
Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Calci | 2019 |
Postoperative atrial fibrillation: mechanisms, manifestations and management.
Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Calci | 2019 |
Postoperative atrial fibrillation: mechanisms, manifestations and management.
Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Calci | 2019 |
Postoperative atrial fibrillation: mechanisms, manifestations and management.
Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Calci | 2019 |
Postoperative atrial fibrillation: mechanisms, manifestations and management.
Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Calci | 2019 |
Timing and route of amiodarone for prevention of postoperative atrial fibrillation after cardiac surgery: a network regression meta-analysis.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Proc | 2013 |
Timing and route of amiodarone for prevention of postoperative atrial fibrillation after cardiac surgery: a network regression meta-analysis.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Proc | 2013 |
Timing and route of amiodarone for prevention of postoperative atrial fibrillation after cardiac surgery: a network regression meta-analysis.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Proc | 2013 |
Timing and route of amiodarone for prevention of postoperative atrial fibrillation after cardiac surgery: a network regression meta-analysis.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Proc | 2013 |
[Total thyroidectomy in patients with amiodarone-induced hyperthyroidism: when does the risk of conservative treatment exceed the risk of surgery?].
Topics: Amiodarone; Anti-Arrhythmia Agents; Evidence-Based Medicine; Humans; Hyperthyroidism; Incidence; Pat | 2014 |
[Anesthetic management of patients with arrhythmogenic right ventricular cardiomyopathy].
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Amiodarone; Anesthesia, General; Anesthesia, | 2014 |
Junctional ectopic tachycardia after congenital heart surgery.
Topics: Age Factors; Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Cardiac Surgical Proced | 2014 |
Impact of pre-implant amiodarone exposure on outcomes in cardiac transplant recipients.
Topics: Amiodarone; Anti-Arrhythmia Agents; Biological Availability; Bradycardia; Drug Interactions; Heart F | 2015 |
[Tetraplegia revealing a severe pneumococcal meningomyelitis: about a case and literature review].
Topics: Amiodarone; Autoimmunity; Blepharoptosis; Ceftriaxone; Cerebrospinal Fluid; Delayed Diagnosis; Dexam | 2015 |
Systematic Review and Meta-analysis of Atrial Fibrillation Prophylaxis After Lung Surgery.
Topics: Amiodarone; Atrial Fibrillation; Humans; Incidence; Lung; Pneumonectomy; Postoperative Complications | 2016 |
Intrapericardial Amiodarone for the Prevention of Postoperative Atrial Fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Humans; Infusions | 2016 |
Intrapericardial Amiodarone for the Prevention of Postoperative Atrial Fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Humans; Infusions | 2016 |
Intrapericardial Amiodarone for the Prevention of Postoperative Atrial Fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Humans; Infusions | 2016 |
Intrapericardial Amiodarone for the Prevention of Postoperative Atrial Fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Humans; Infusions | 2016 |
Preoperative Plasma Aldosterone Levels and Postoperative Atrial Fibrillation Occurrence Following Cardiac Surgery: A Review of Literature and Design of the ALDO-POAF Study (ALDOsterone for Prediction of Post-Operative Atrial Fibrillation).
Topics: Adrenergic beta-Antagonists; Aldosterone; Amiodarone; Atrial Fibrillation; Biomarkers; Cardiac Surgi | 2016 |
Acute Amiodarone Pulmonary Toxicity After Surgical Procedures.
Topics: Amiodarone; Anti-Arrhythmia Agents; Humans; Postoperative Complications; Respiratory Distress Syndro | 2016 |
Pre-cardiac transplant amiodarone use is not associated with postoperative mortality: An updated meta-analysis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Controlled Clinical Trials as Topic; Heart Transplantation; Huma | 2017 |
Management of postoperative atrial fibrillation.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Inflammatory Agents; Atrial Fibrillation; Cardiac Paci | 2012 |
Postoperative wide complex tachycardia: an alternative hypothesis.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Aortic Valve Stenosis; Atrial Fibrillation; Electrocardiog | 2013 |
Meta-analysis of amiodarone versus β-blocker as a prophylactic therapy against atrial fibrillation following cardiac surgery.
Topics: Adrenergic beta-Antagonists; Amiodarone; Atrial Fibrillation; Cardiac Surgical Procedures; Humans; P | 2012 |
[Management of lethal ventricular arrhythmias after cardiac surgery].
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Cardiac Surgical Procedures; Cardiop | 2002 |
Meta-analysis of antiarrhythmic therapy in the prevention of postoperative atrial fibrillation and the effect on hospital length of stay, costs, cerebrovascular accidents, and mortality in patients undergoing cardiac surgery.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Cardiac Surgica | 2003 |
Atrial fibrillation after cardiac surgery: update on the evidence on the available prophylactic interventions.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing | 2003 |
Atrial fibrillation in patients after cardiovascular surgery: incidence, risk factors, preventive and therapeutic strategies.
Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardi | 2003 |
Atrial fibrillation after cardiac surgery: evidence on prophylactic interventions.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing | 2003 |
Selective use of amiodarone and early cardioversion for postoperative atrial fibrillation.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial | 2005 |
Hepatotoxicity during rapid intravenous loading with amiodarone: Description of three cases and review of the literature.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Chemical and Drug Induced Liver Injur | 2005 |
Pharmacologic prophylaxis for postoperative atrial tachyarrhythmia in general thoracic surgery: evidence from randomized clinical trials.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial F | 2005 |
Effect of prophylactic amiodarone on clinical and economic outcomes after cardiothoracic surgery: a meta-analysis.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Coronary | 2005 |
Atrial arrhythmias after cardiac surgery in patients with diabetes mellitus.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgic | 2006 |
Safety of amiodarone in the prevention of postoperative atrial fibrillation: a meta-analysis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery Bypass; Humans; Postoperati | 2006 |
Atrial fibrillation post-cardiac surgery: changing perspectives.
Topics: Amiodarone; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Atrial Fibrillation; Cardiac Surgical | 2006 |
Amiodarone prophylaxis for atrial fibrillation after cardiac surgery: meta-analysis of dose response and timing of initiation.
Topics: Amiodarone; Atrial Fibrillation; Humans; Incidence; Postoperative Complications; Postoperative Perio | 2007 |
Amiodarone prophylaxis for atrial fibrillation after cardiac surgery: meta-analysis of dose response and timing of initiation.
Topics: Amiodarone; Atrial Fibrillation; Humans; Incidence; Postoperative Complications; Postoperative Perio | 2007 |
Amiodarone prophylaxis for atrial fibrillation after cardiac surgery: meta-analysis of dose response and timing of initiation.
Topics: Amiodarone; Atrial Fibrillation; Humans; Incidence; Postoperative Complications; Postoperative Perio | 2007 |
Amiodarone prophylaxis for atrial fibrillation after cardiac surgery: meta-analysis of dose response and timing of initiation.
Topics: Amiodarone; Atrial Fibrillation; Humans; Incidence; Postoperative Complications; Postoperative Perio | 2007 |
Prevention of atrial fibrillation after cardiac surgery.
Topics: Adrenergic beta-Antagonists; Amiodarone; Atrial Fibrillation; Cardiac Surgical Procedures; Chemoprev | 2007 |
[Pharmacological therapy for atrial fibrillation after cardiac surgery].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anticoagulants; Atrial Fibrillation; Calcium Channel Blocke | 2007 |
Amiodarone for atrial fibrillation following cardiac surgery: development of clinical practice guidelines at a university hospital.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Follow-Up Stud | 2008 |
[Supraventricular arrhythmia after pneumonectomy. Apropos of 100 cases and review of the literature].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Humans; Lung Neoplasms; Male; | 1998 |
Unexpected instant death following successful coronary artery bypass graft surgery (and other clinical settings): atrial fibrillation, quinidine, procainamide, et cetera, and instant death.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Coronary Artery B | 1998 |
Intravenous antiarrhythmic regimens with focus on amiodarone for prophylaxis of atrial fibrillation after open heart surgery.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Coronary Artery B | 1999 |
Prevention of atrial fibrillation in the postoperative cardiac patient: significance of oral class III antiarrhythmic agents.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as To | 1999 |
Postoperative arrhythmias and conduction disorders.
Topics: Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Surgical Procedures; | 2001 |
Amiodarone vs. sotalol as prophylaxis against atrial fibrillation/flutter after heart surgery: a meta-analysis.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Coronary Artery Bypas | 2002 |
Role of amiodarone in reducing atrial fibrillation after cardiac surgery in adults.
Topics: Adult; Amiodarone; Atrial Fibrillation; Coronary Artery Bypass; Double-Blind Method; Drug Evaluation | 2002 |
[Ventricular tachycardia in anterior wall aneurysm after myocardial infarct].
Topics: Aged; Amiodarone; Drug Therapy, Combination; Electrocardiography, Ambulatory; Heart Aneurysm; Heart | 1992 |
64 trials available for amiodarone and Postoperative Complications
| Article | Year |
|---|---|
Amiodarone with or without N-Acetylcysteine for the Prevention of Atrial Fibrillation after Thoracic Surgery: A Double-blind, Randomized Trial.
Topics: Acetylcysteine; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery Bypass; Dou | 2022 |
Preventive Effect of Berberine on Postoperative Atrial Fibrillation.
Topics: Amiodarone; Atrial Fibrillation; Berberine; Biomarkers; C-Reactive Protein; Humans; Interleukins; Li | 2022 |
Screening and Prophylactic Amiodarone Reduces Post-Operative Atrial Fibrillation in At-Risk Patients.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Humans; | 2020 |
Ivabradine Versus Amiodarone in the Management of Postoperative Junctional Ectopic Tachycardia: A Randomized, Open-Label, Noninferiority Study.
Topics: Adolescent; Amiodarone; Cardiac Surgical Procedures; Child; Humans; Ivabradine; Postoperative Compli | 2021 |
Prophylaxis for patients at Risk to Eliminate Post-operative Atrial Fibrillation (PREP-AF trial): a protocol for a feasibility randomized controlled study.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Feasibility Studies; Humans; Multicenter St | 2021 |
Prophylactic amiodarone vs dronedarone for prevention of perioperative arrhythmias in offpump coronary artery bypass grafting: A pilot randomized controlled trial.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Artery Bypass; Dronedarone; Human | 2017 |
Pharmacological Prophylaxis of Atrial Fibrillation After Surgical Myocardial Revascularization.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Therapy, | 2019 |
Prophylaxis against atrial fibrillation after cardiac surgery: beneficial effect of perioperative metoprolol.
Topics: Administration, Oral; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgica | 2013 |
Amiodarone is a cost-neutral way of preventing atrial fibrillation after surgery for lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Denmark; Fe | 2014 |
Is the Preoperative Administration of Amiodarone or Metoprolol More Effective in Reducing Atrial Fibrillation: After Coronary Bypass Surgery?
Topics: Age Factors; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Comorbidity; Coronary Ar | 2015 |
Safety and Efficacy of Prophylactic Amiodarone in Preventing Early Junctional Ectopic Tachycardia (JET) in Children After Cardiac Surgery and Determination of Its Risk Factor.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Bypass; Child; Egypt; Female; Heart | 2016 |
Rate Control versus Rhythm Control for Atrial Fibrillation after Cardiac Surgery.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2016 |
Rate Control versus Rhythm Control for Atrial Fibrillation after Cardiac Surgery.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2016 |
Rate Control versus Rhythm Control for Atrial Fibrillation after Cardiac Surgery.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2016 |
Rate Control versus Rhythm Control for Atrial Fibrillation after Cardiac Surgery.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhyt | 2016 |
[The comparison between the efficiency of different anti-arrhythmic agents in preventing postoperative atrial fibrillation after open heart surgery].
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Proc | 2008 |
Postoperative oral amiodarone versus oral bisoprolol as prophylaxis against atrial fibrillation after coronary artery bypass graft surgery: a prospective randomized trial.
Topics: Administration, Oral; Aged; Amiodarone; Atrial Fibrillation; Bisoprolol; Coronary Artery Bypass; Fem | 2009 |
Does stopping amiodarone after successfully treating atrial fibrillation occurring after cardiac surgery increase the risk of recurrence?
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiovascu | 2008 |
A randomized trial evaluating amiodarone for prevention of atrial fibrillation after pulmonary resection.
Topics: Administration, Oral; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Carcinoma, Non- | 2009 |
Ability of amiodarone and propranolol alone or in combination to prevent post-coronary bypass atrial fibrillation.
Topics: Adult; Aged; Amiodarone; Atrial Fibrillation; Coronary Artery Bypass; Double-Blind Method; Drug Ther | 2009 |
Perioperative intravenous amiodarone does not reduce the burden of atrial fibrillation in patients undergoing cardiac valvular surgery.
Topics: Aged; Amiodarone; Anesthesia; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedur | 2010 |
Amiodarone significantly decreases atrial fibrillation in patients undergoing surgery for lung cancer.
Topics: Aged; Aged, 80 and over; Amiodarone; Atrial Fibrillation; Double-Blind Method; Female; Humans; Lung | 2012 |
Postoperative oral amiodarone as prophylaxis against atrial fibrillation after coronary artery surgery.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; | 2002 |
Low-dose oral amiodarone prophylaxis reduces atrial fibrillation after pulmonary resection.
Topics: Administration, Oral; Aged; Aged, 80 and over; Amiodarone; Atrial Fibrillation; Confidence Intervals | 2003 |
Amiodarone reduces the incidence of atrial fibrillation after coronary artery bypass grafting.
Topics: Administration, Oral; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary | 2003 |
Effect of right atrial pacing, intravenous amiodarone and beta blockers for suppression of atrial fibrillation after coronary artery bypass surgery: a pilot study.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibril | 2003 |
Amiodarone prevents symptomatic atrial fibrillation and reduces the risk of cerebrovascular accidents and ventricular tachycardia after open heart surgery: results of the Atrial Fibrillation Suppression Trial (AFIST).
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial | 2003 |
Rate-control versus conversion strategy in postoperative atrial fibrillation: trial design and pilot study results.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Atrial Fib | 2003 |
Supraventricular tachyarrythmia prophylaxis after coronary artery surgery in chronic obstructive pulmonary disease patients (early amiodarone prophylaxis trial).
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Coronary Artery Bypass; Female; Forced Expiratory Volume; | 2004 |
A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo-controlled trial.
Topics: Administration, Oral; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgica | 2004 |
An evaluation of postoperative P-wave variables after cardiothoracic surgery.
Topics: Aged; Amiodarone; Atrial Fibrillation; Cardiac Pacing, Artificial; Cardiac Surgical Procedures; Elec | 2004 |
Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS).
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Canada; Comorbidity; Coronary Artery Bypass; Death, Sudden | 2004 |
Economic analysis of intravenous plus oral amiodarone, atrial septal pacing, and both strategies to prevent atrial fibrillation after open heart surgery.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artif | 2004 |
Giving IV and oral amiodarone perioperatively for the prevention of postoperative atrial fibrillation in patients undergoing coronary artery bypass surgery: the GAP study.
Topics: Administration, Oral; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Case-Control St | 2004 |
Amiodarone versus sotalol for the treatment of atrial fibrillation after open heart surgery: the Reduction in Postoperative Cardiovascular Arrhythmic Events (REDUCE) trial.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Coronary | 2004 |
Impact of fluid balance on incidence of atrial fibrillation after cardiothoracic surgery.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery Bypass; Female; Fluid | 2004 |
Effects of late regain of sinus rhythm on pulmonary artery pressure and functional status in patients with mitral valve replacement surgery and atrial fibrillation.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Echocardiography, Doppler; Electric | 2004 |
Effects of amiodarone and thoracic epidural analgesia on atrial fibrillation after coronary artery bypass grafting.
Topics: Aged; Amiodarone; Analgesia, Epidural; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery | 2004 |
Hybrid therapy with right atrial catheter ablation and previously ineffective antiarrhythmic drugs for the management of atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Combined Modality Therap | 2005 |
Effectiveness of the maze procedure using cooled-tip radiofrequency ablation in patients with permanent atrial fibrillation and rheumatic mitral valve disease.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Catheter Ablat | 2005 |
Amiodarone prophylaxis for atrial fibrillation of high-risk patients after coronary bypass grafting: a prospective, double-blinded, placebo-controlled, randomized study.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery Bypass; Critical Care | 2006 |
Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of the first phase I cohort of patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Cicatrix; Cohort Studies; Combined Modality Th | 2006 |
Impact of epicardial anterior fat pad retention on postcardiothoracic surgery atrial fibrillation incidence: the AFIST-III Study.
Topics: Adipose Tissue; Adrenergic beta-Antagonists; Aged; Amiodarone; Analysis of Variance; Atrial Fibrilla | 2007 |
Practical regimen for amiodarone use in preventing postoperative atrial fibrillation.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fib | 2007 |
Practical regimen for amiodarone use in preventing postoperative atrial fibrillation.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fib | 2007 |
Practical regimen for amiodarone use in preventing postoperative atrial fibrillation.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fib | 2007 |
Practical regimen for amiodarone use in preventing postoperative atrial fibrillation.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fib | 2007 |
Intravenous and oral amiodarone for the prevention of postoperative atrial fibrillation in patients undergoing off-pump coronary artery bypass surgery.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Combined Modality The | 2007 |
Prospective evaluation of serum amiodarone concentrations when administered via a nasogastric tube into the stomach conduit after transthoracic esophagectomy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Biological Availability; Drug Administration Routes; Esophagecto | 2007 |
Impact of amiodarone on the ability of anterior fat pad retention to prevent postcoronary arterial bypass grafting atrial fibrillation incidence: a substudy of the AFIST III (Atrial Fibrillation Suppression Trial III).
Topics: Adipose Tissue; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Connecticut; Coronary | 2008 |
Amiodarone cost effectiveness in preventing atrial fibrillation after coronary artery bypass graft surgery.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Analysis of Variance; Anti-Arrhythmia Agents; Atrial Fib | 2008 |
Are patients receiving amiodarone at increased risk for cardiac operations?
Topics: Aged; Amiodarone; Combined Modality Therapy; Female; Follow-Up Studies; Hemodynamics; Hospital Morta | 1994 |
A comparison of amiodarone and digoxin for treatment of supraventricular arrhythmias after cardiac surgery.
Topics: Aged; Amiodarone; Atrial Fibrillation; Atrial Flutter; Cardiac Surgical Procedures; Digoxin; Female; | 1994 |
Amiodarone prophylaxis for tachycardias after coronary artery surgery: a randomised, double blind, placebo controlled trial.
Topics: Adult; Aged; Amiodarone; Cardiac Surgical Procedures; Double-Blind Method; Electrocardiography, Ambu | 1993 |
Amiodarone and the development of ARDS after lung surgery.
Topics: Adult; Aged; Amiodarone; Atrial Fibrillation; Humans; Incidence; Middle Aged; Pneumonectomy; Postope | 1994 |
Intravenous amiodarone vs propafenone for atrial fibrillation and flutter after cardiac operation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Coronary Disease; Dos | 1995 |
Verapamil as prophylactic treatment for atrial fibrillation after lung operations.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Humans; Hypotension; Incidence | 1996 |
Relationship of amiodarone to postoperative complications of transthoracic implantation of automatic implantable cardioverter defibrillators.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Impl | 1996 |
Low-dose amiodarone-related complications after cardiac operations.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiac Surgical Procedures; Cardiotonic Agents; Female; Humans; | 1997 |
Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Double-B | 1997 |
Intraoperative amiodarone as prophylaxis against atrial fibrillation after coronary operations.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Coronary Artery Bypass; Female | 2000 |
Intravenous amiodarone for prevention of atrial fibrillation after coronary artery bypass grafting.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery Bypass; Female; Human | 2000 |
Intravenous amiodarone or magnesium sulphate is not cost-beneficial prophylaxis for atrial fibrillation after coronary artery bypass surgery.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Carbon Diox | 2000 |
Effect of amiodarone on atrial fibrillation after coronary artery bypass surgery.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery Bypass; Female; Humans; Inf | 2001 |
Amiodarone versus a beta-blocker to prevent atrial fibrillation after cardiovascular surgery.
Topics: Aged; Amiodarone; Atrial Fibrillation; Coronary Artery Bypass; Coronary Disease; Heart Valves; Human | 2001 |
Prevention of atrial fibrillation after cardiac surgery: the significance of postoperative oral amiodarone.
Topics: Administration, Oral; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiopulmonary | 2001 |
Amiodarone versus digoxin and metoprolol combination for the prevention of postcoronary bypass atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery Bypass; Digoxin; Drug Thera | 2002 |
Amiodarone therapy does not compromise subsequent heart transplantation.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Cardiotonic Agents; Feasibility | 1992 |
Electrocardiographic and antiarrhythmic effects of intravenous amiodarone: results of a prospective, placebo-controlled study.
Topics: Aged; Amiodarone; Analysis of Variance; Arrhythmias, Cardiac; Atrial Fibrillation; Chi-Square Distri | 1991 |
Amiodarone and N-desethylamiodarone concentrations in plasma, red blood cells, and myocardium after a single oral dose: relation to hemodynamic effects in surgical patients.
Topics: Administration, Oral; Adult; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Blood Pressure; Erythroc | 1986 |
135 other studies available for amiodarone and Postoperative Complications
| Article | Year |
|---|---|
Postoperative Atrial Fibrillation After Surgical Aortic Valve Replacement: Amiodarone and Warfarin Use.
Topics: Amiodarone; Anticoagulants; Aortic Valve; Atrial Fibrillation; Humans; Postoperative Complications; | 2023 |
Reducing New-Onset Atrial Fibrillation After Coronary Artery Bypass Graft Surgery.
Topics: Administration, Oral; Age Factors; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Co | 2019 |
Sustained left ventricular outflow tract ventricular tachycardia following transcatheter aortic valve replacement.
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Aortic Valve Stenosis; Electrocardiography; H | 2017 |
Topical amiodarone during cardiac surgery: Does epicardial application of amiodarone prevent postoperative atrial fibrillation?
Topics: Administration, Topical; Age Factors; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; | 2017 |
Outcomes after repeat ablation of ventricular tachycardia in structural heart disease: An analysis from the International VT Ablation Center Collaborative Group.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Catheter Ablation; Electric Countershock; Electrocardiogra | 2017 |
Management of postoperative junctional ectopic tachycardia in pediatric patients: a survey of 30 centers in Germany, Austria, and Switzerland.
Topics: Amiodarone; Anti-Arrhythmia Agents; Austria; Cardiac Pacing, Artificial; Cardiac Surgical Procedures | 2017 |
Pulmonary embolism four days after interruption of therapy with rivaroxaban.
Topics: Administration, Oral; Amiodarone; Atrial Fibrillation; Drug Administration Schedule; Drug Therapy, C | 2017 |
Aiming at a Blurry Target: Optimal Therapy for Postoperative JET.
Topics: Amiodarone; Anti-Arrhythmia Agents; Heart Defects, Congenital; Humans; Infant; Postoperative Complic | 2017 |
Amiodarone Protocol Provides Cost-Effective Reduction in Postoperative Atrial Fibrillation.
Topics: Aged; Amiodarone; Atrial Fibrillation; Cardiac Surgical Procedures; Case-Control Studies; Cohort Stu | 2018 |
Intravenous amiodarone-induced acute liver failure in cardiac surgery intensive care unit.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Critical | 2018 |
Cough as the sole manifestation of pericardial effusion.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Cough; Echocardiography; | 2018 |
Impact and treatment success of new-onset atrial fibrillation with rapid ventricular rate development in the surgical intensive care unit.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Critical Pathways; | 2018 |
Topics: Amiodarone; Brain Neoplasms; Defibrillators, Implantable; Diagnosis, Differential; Glioblastoma; Hum | 2019 |
Quinidine-Responsive Polymorphic Ventricular Tachycardia in Patients With Coronary Heart Disease.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Coronary Artery Disease; Drug Evaluation; Drug Resistance; | 2019 |
Use and Outcomes Associated With Perioperative Amiodarone in Cardiac Surgery.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cohort Studies; Coron | 2019 |
[Prophylactic use of VFS in patients with coronary artery disease in the perioperative coronary artery bypass grafting].
Topics: Aconitine; Amiodarone; Anti-Arrhythmia Agents; Chemoprevention; Comparative Effectiveness Research; | 2013 |
[Clinical pharmacist intercepts iatrogenic event through medication reconciliation: a case report].
Topics: Amiodarone; Anti-Arrhythmia Agents; Appendicitis; Belgium; Digoxin; Drug Information Services; Human | 2013 |
A novel amiodarone-eluting biological glue for reducing postoperative atrial fibrillation: first animal trial.
Topics: Alginates; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Biocompatible Materials | 2014 |
[Therapeutic use of amiodarone against postoperative fibrillation after cardiac surgery].
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Heart Dise | 2014 |
Does the addition of atrial pacing to amiodarone reduce the incidence of postoperative atrial fibrillation: a pilot study.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Electrocardiogr | 2014 |
Use of amiodarone after major lung resection.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Middle Age | 2014 |
[Neurogenic stunned myocardium in Pediatrics. A case report].
Topics: Acute Coronary Syndrome; Amiodarone; Cerebellar Neoplasms; Child, Preschool; Diagnosis, Differential | 2015 |
New-Onset Heart Failure in a Patient With a Pacemaker: An Unusual Cause.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Aortic Valve Stenosis; Atrial Fibrillation; Bisoprolol; Ca | 2016 |
Efficacy and Safety of Landiolol Compared to Amiodarone for the Management of Postoperative Atrial Fibrillation in Intensive Care Patients.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Critical Care; Female; Humans; Male; | 2016 |
Long-term use of amiodarone before heart transplantation significantly reduces early post-transplant atrial fibrillation and is not associated with increased mortality after heart transplantation.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Heart Transplantation; | 2016 |
Is Less More for the Treatment of Atrial Fibrillation after Cardiac Surgery?
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Female; Heart | 2016 |
LASIK and surface ablation in patients treated with amiodarone.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Contraindications; Female; Human | 2016 |
Amiodarone use in patients listed for heart transplant is associated with increased 1-year post-transplant mortality.
Topics: Adult; Age Factors; Allografts; Amiodarone; Cause of Death; Cohort Studies; Female; Graft Rejection; | 2017 |
To use or not to use? Amiodarone before heart transplantation.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Cohort Studies; Drug Administration Schedule; Femal | 2017 |
Combination prophylactic therapy for post-operative atrial fibrillation.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgic | 2008 |
Impact of early and standardized treatment with amiodarone on therapeutic success and outcome in pediatric patients with postoperative tachyarrhythmia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Blood Pressure; Central Venous Pressure; Critical Care; Heart De | 2008 |
Successful use of intravenous amiodarone in a child with combined postoperative junctional and ectopic tachycardias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiac Surgical Procedures; Child, Preschool; Electrocardiograp | 2009 |
Current use of prophylactic strategies for postoperative atrial fibrillation: a survey of Canadian cardiac surgeons.
Topics: Adrenal Cortex Hormones; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical P | 2009 |
Amiodarone as a first-line therapy for postoperative junctional ectopic tachycardia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Blood Pressure; Cardiac Surgical Procedures; Child; Child, Presc | 2009 |
Invited commentary.
Topics: Age Factors; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Atrial Fi | 2009 |
[Clinical analysis of precaution against atrial fibrillation following cardiac surgery: landiolol or amiodarone?].
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac | 2010 |
Atrial fibrillation after cardiac surgery: incidence, risk factors, and economic burden.
Topics: Age Factors; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedu | 2010 |
[Successful use of intravenous amiodarone for refractory ventricular fibrillation just after releasing aortic cross-clamp].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Aortic Valve Stenosis; Cardiopulmonary Bypass; Humans; Inj | 2010 |
[Flecainide poisoning].
Topics: Aged; Amiodarone; Atrial Fibrillation; Cholecystectomy; Cholecystitis; Electrocardiography; Emergenc | 2010 |
[Rhabdomyolysis associated with atorvastatin combined with amiodarone and fluconazole].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Anticholesteremic Agents; Antifungal Agents; Atorvastatin; | 2011 |
[Prophylactic use of amiodarone against postoperative atrial fibrillation after cardiac surgery].
Topics: Aged; Amiodarone; Atrial Fibrillation; Coronary Artery Bypass; Female; Heart Valves; Humans; Male; P | 2011 |
[Treatment of atrial fibrillation: when to use drugs or to perform ablation].
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Clinical Trials as Topic | 2010 |
[Postoperative management of postpneumonectomy pulmonary edema in a patient with ostium secundum atrial septal defect].
Topics: Adenocarcinoma; Amiodarone; Bundle-Branch Block; Combined Modality Therapy; Diuretics; Electric Coun | 2011 |
Cryoablation of atrial fibrillation in cardiac surgery: outcomes and myocardial injury biomarkers.
Topics: Aged; Amiodarone; Anesthesia; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Biomarker | 2011 |
Prophylactic amiodarone reduces junctional ectopic tachycardia after tetralogy of Fallot repair.
Topics: Amiodarone; Anti-Arrhythmia Agents; Child, Preschool; Humans; Postoperative Complications; Retrospec | 2012 |
Short-term onset of fatal pulmonary toxicity in a patient treated with intravenous amiodarone for post-operative atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Fatal Outcome; Humans; Infusions, Int | 2012 |
[Comparative study between landiolol and amiodarone for therapeutic efficacy after open heart surgery].
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiac Surgical Procedures; | 2011 |
Ultra-short course of low-dose amiodarone-induced post-operative fatal pulmonary toxicity.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery Bypass; Drug-Related Side E | 2011 |
CASE 6--2012: suspected amiodarone hepatotoxicity after cardiac surgery.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Arter | 2012 |
Total thyroidectomy for amiodarone-associated thyrotoxicosis: should surgery always be delayed for pre-operative medical preparation?
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Arrhythmias, | 2012 |
Total thyroidectomy in patients with amiodarone-induced thyrotoxicosis and severe left ventricular systolic dysfunction.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Female; Heart Diseases; Humans; Male; Middle Aged; Postope | 2012 |
Cost-effectiveness of targeting patients undergoing cardiac surgery for therapy with intravenous amiodarone to prevent atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery Bypass; Cost-Benefit | 2002 |
Postoperative junctional ectopic tachycardia in children: incidence, risk factors, and treatment.
Topics: Amiodarone; Cardiac Pacing, Artificial; Child; Child, Preschool; Dopamine; Female; Heart Defects, Co | 2002 |
[Arrhythmias after surgery for congenital heart disease].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electroencephalography; Exercise Test; Hea | 2002 |
Atrial fibrillation after adult lung transplantation.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Lung Transplantation; Postop | 2003 |
A simplified amiodarone regimen to prevent postoperative atrial fibrillation.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiopulmonary Bypas | 2003 |
Is it time to choose amiodarone for postoperative atrial fibrillation?
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Postoperative Complications | 2003 |
Clinical outcome of very late recurrence of atrial fibrillation after catheter ablation of paroxysmal atrial fibrillation.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Electrophys | 2003 |
Amiodarone therapy before heart transplantation as a predictor of thyroid dysfunction after transplantation.
Topics: Adolescent; Adult; Amiodarone; Anti-Arrhythmia Agents; Child; Cohort Studies; Female; Heart Transpla | 2003 |
Impact of left atrial size reduction on chronic atrial fibrillation in mitral valve surgery.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pac | 2003 |
Comparison of survival and other complications after heart transplantation in patients taking amiodarone before surgery versus those not taking amiodarone.
Topics: Adult; Aged; Amiodarone; Female; Heart Failure; Heart Transplantation; Humans; Male; Middle Aged; Po | 2004 |
New-onset postoperative atrial fibrillation: a riddle wrapped in a mystery inside an enigma.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Arter | 2004 |
Ventral cardiac denervation reduces the incidence of atrial fibrillation after coronary artery bypass grafting.
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillat | 2004 |
[Anaesthesia and amiodarone-associated hyperthyroidism].
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anesthesia, General; Anti-Arrhythmia Agents; Female; Hum | 2004 |
Radiofrequency catheter ablation of a macroreentrant ventricular tachycardia late after surgical repair of tetralogy of Fallot using the electroanatomic mapping (CARTO).
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Catheter Ablation; Cicatrix; | 2004 |
Unidirectional atrio-atrial conduction after surgical isolation of the posterior part of the left atrium and pulmonary veins for atrial fibrillation: simple postsurgical procedure electrophysiological evaluation.
Topics: Adenosine Triphosphate; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cryosurgery; | 2004 |
High-dosage continuous amiodarone therapy to treat new-onset supraventricular tachyarrhythmias in surgical intensive care patients: an observational study.
Topics: Acid-Base Equilibrium; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Bilirubin; Creat | 2004 |
Is a charge a cost if nobody pays it?
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery Bypass; Cost Savings; Hospi | 2004 |
Left atrial thrombus formation early after mitral valve replacement.
Topics: Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Cardiac Output, Low; Echoca | 2004 |
Salvage application of secondary blood cardioplegia in intractable ventricular fibrillation.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Blood Gas Analysis; Cardiopulmonary Bypass; Dose-Response | 2004 |
Recurrence of atrial fibrillation and flutter after atrial compartment operation: modified atrial incisions and role of amiodarone.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cryosurgery; Heart Atria; H | 2005 |
Intravenous amiodarone: offender or bystander?
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Chemical and Drug Induced Liver Injury; Critical Care; Dia | 2005 |
The use of prophylactic amiodarone after cardiothoracic surgery reduces the incidence of atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Incidence; Postoperative Complicati | 2005 |
Impact of prophylactic amiodarone on length of hospital stay, stroke, and atrial fibrillation after cardiothoracic surgery.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Cohort S | 2005 |
Successful use of an intravenous infusion of flecainide and amiodarone for a refractory combination of postoperative junctional and ectopic tachycardias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiac Surgical Procedures; Drug Therapy, Combination; Electroc | 2005 |
[Radiofrequency ablation of ventricular tachycardia in a patient after surgery for Tetralogy of Fallot: case report].
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Catheter Ablation; Electrocardiography; Female; Humans; P | 2005 |
[Atrial fibrillation after isolated coronary bypass surgery].
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary | 2005 |
Supraventricular tachyarrhythmia as early indicator of a complicated course after esophagectomy.
Topics: Adrenergic Agonists; Adrenergic beta-Antagonists; Age Factors; Amiodarone; Anastomosis, Surgical; An | 2005 |
Acute lung toxicity after total cystectomy.
Topics: Amiodarone; Blood Transfusion; Cystectomy; Humans; Lung Diseases; Postoperative Complications; Vasod | 2005 |
Pharmacological management of atrial fibrillation following cardiac surgery.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium Channe | 2005 |
Amiodarone-induced acute lung toxicity in an ICU setting.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Lung Diseases; Postoperative Compli | 2006 |
Management of cardiovascular risk in patients receiving calcineurin inhibitors--a case report.
Topics: Acenocoumarol; Amiodarone; Angioplasty; Calcineurin Inhibitors; Carbazoles; Carvedilol; Cyclosporine | 2006 |
[Myocarditis and arrhythmogenic dysplasia of right ventricle].
Topics: Aged; Amiodarone; Arrhythmogenic Right Ventricular Dysplasia; Bundle-Branch Block; Cardiac Pacing, A | 2006 |
Selective prophylaxis of atrial fibrillation with amiodarone after cardiac surgery.
Topics: Algorithms; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Fe | 2006 |
Case 1-2007 morbidly obese patient undergoing cardiac surgery.
Topics: Amiodarone; Anesthesia, General; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Catheterizatio | 2007 |
Administration of amiodarone into the aortic root for persistent ventricular fibrillation after aortic valve replacement.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Aortic Valve; Aortic Valve Insufficiency; Cardiopulmonary | 2007 |
Amiodarone and cardiac surgery.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Surgical Pro | 2007 |
Prevention of atrial fibrillation with moderate doses of amiodarone in the postoperative period of cardiac surgery is safe and effective in patients with high risk for developing this arrhythmia.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillati | 2007 |
Dolasetron-induced torsades de pointes.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Antiemetics; Cardiopulmonary Resusc | 2007 |
Incidence and pathophysiology of atrioventricular block following mitral valve replacement and ring annuloplasty.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arteries; Atrioventricular Block; Atrio | 2008 |
Five patients with iodine-induced hyperthyroidism.
Topics: Adult; Amiodarone; Chlorobutanol; Coloring Agents; Coronary Artery Bypass; Drug Combinations; Female | 1984 |
[Amiodarone in the acute treatment of hyperkinetic arrhythmias in cardiosurgery].
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Drug Evaluation; Female; Heart Diseases; | 1983 |
Intravenous amiodarone in the treatment of various arrhythmias following cardiac operations.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cardiac Surgical Procedures; Female; Hum | 1981 |
Amiodarone for ventricular tachycardia after coronary artery bypass grafting.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Coronary Artery Bypass; Humans; Infusio | 1995 |
Surgical management of hypertrophic obstructive cardiomyopathy. Early and late results.
Topics: Aged; Aged, 80 and over; Amiodarone; Cardiomyopathy, Hypertrophic; Chi-Square Distribution; Coronary | 1995 |
Amiodarone and the development of ARDS after lung surgery.
Topics: Amiodarone; Humans; Pneumonectomy; Postoperative Complications; Respiratory Distress Syndrome | 1995 |
Amiodarone and the development of ARDS after lung surgery.
Topics: Amiodarone; Arrhythmias, Cardiac; Humans; Pneumonectomy; Postoperative Complications; Respiratory Di | 1995 |
Conduction disturbances after open heart operation in a patient receiving amiodarone.
Topics: Amiodarone; Atrial Fibrillation; Female; Heart Block; Heart Valve Prosthesis; Humans; Middle Aged; P | 1994 |
Amiodarone management of junctional ectopic tachycardia after cardiac surgery in children.
Topics: Adolescent; Amiodarone; Cardiac Pacing, Artificial; Cardiopulmonary Bypass; Child, Preschool; Combin | 1994 |
Primum non nocere. Is the therapy worse than the disease?
Topics: Amiodarone; Humans; Lung; Lung Diseases, Interstitial; Pneumonectomy; Postoperative Complications; P | 1994 |
Development of atypical amiodarone keratopathy in a corneal graft.
Topics: Aged; Amiodarone; Cornea; Corneal Diseases; Corneal Transplantation; Humans; Male; Postoperative Com | 1993 |
Amiodarone-induced thyrotoxicosis: clinical presentation and expanded indications for thyroidectomy.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Male; Middle Aged; Postoperative Complicat | 1993 |
Radiofrequency ablation of the His bundle for malignant atrial flutter after Mustard procedure for transposition of the great arteries.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Atrial Flutter; Bundle of His; Catheter Ablation; Hu | 1996 |
[Treatment and prognosis of tachyarrhythmia after atrial surgical repair of transposition of great vessels].
Topics: Adolescent; Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Card | 1996 |
Redistribution of amiodarone in heart transplant recipients treated with the drug before operation.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Female; Heart Transplantation; Human | 1997 |
Amiodarone as treatment for atrial tachycardias after surgery.
Topics: Administration, Oral; Adolescent; Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Flutter; Cathete | 1997 |
Preoperative therapy with amiodarone and the incidence of acute organ dysfunction after cardiac surgery.
Topics: Acute Disease; Amiodarone; Anti-Arrhythmia Agents; Blood Chemical Analysis; Cardiac Surgical Procedu | 1997 |
Amiodarone prophylaxis for atrial fibrillation after cardiac surgery.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgic | 1998 |
Amiodarone prophylaxis for atrial fibrillation after cardiac surgery.
Topics: Age Factors; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; C | 1998 |
Amiodarone prophylaxis for atrial fibrillation after cardiac surgery.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Humans; Postop | 1998 |
Case-control and cohort studies in anesthesia.
Topics: Amiodarone; Anesthesia; Anti-Arrhythmia Agents; Case-Control Studies; Cohort Studies; Humans; Postop | 1998 |
[Use of high-dose oral amiodarone for the reversion of atrial fibrillation during the postoperative period of cardiac surgery].
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Humans; Male; | 1997 |
[Thyrotoxicosis induced by amiodarone].
Topics: Amiodarone; Anti-Arrhythmia Agents; Female; Hematoma; Humans; Middle Aged; Postoperative Complicatio | 1998 |
[Thyrotoxicosis induced by amiodarone].
Topics: Amiodarone; Anti-Arrhythmia Agents; Female; Hematoma; Humans; Middle Aged; Postoperative Complicatio | 1998 |
Progressive brown discoloration of silicone intraocular lenses after vitrectomy in a patient on amiodarone.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood-Aqueous Barrier; Color; Diseas | 1999 |
Oral amiodarone reduces incidence of postoperative atrial fibrillation.
Topics: Administration, Oral; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiopu | 1999 |
Supraventricular arrhythmia following lung resection for non-small cell lung cancer and its treatment with amiodarone.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Carcinoma, Non-Small-Cell Lung; | 2000 |
Post-discharge recurrences of new-onset atrial fibrillation following cardiac surgery: impact of low-dose amiodarone and beta-blocker prophylaxis.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac | 2000 |
Thyroidectomy for selected patients with thyrotoxicosis.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Female; Graves Disease; Humans; Hypocalcemia; Male; Medi | 2001 |
[Diagnostic quiz. Increasing dyspnea after bypass operation. Interstitial lung disease].
Topics: Aged; Amiodarone; Coronary Artery Bypass; Humans; Lung Diseases, Interstitial; Male; Myocardial Infa | 2001 |
Bleeding complication during coumarin therapy due to amiodarone and azithromycin.
Topics: Amiodarone; Anticoagulants; Atrial Fibrillation; Azithromycin; Coumarins; Drug Interactions; Fatal O | 2000 |
Impact of junctional ectopic tachycardia on postoperative morbidity following repair of congenital heart defects.
Topics: Amiodarone; Analysis of Variance; Cardiac Pacing, Artificial; Cardiac Surgical Procedures; Child; Ch | 2002 |
[The treatment of postoperative junctional ectopic tachycardia].
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiac Surgical Procedures; Combined Modality Therapy; Female; | 2002 |
[Anti-arrhthmic effects of injectable amiodarone in resuscitation during cardiovascular surgery, 2 cases].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Cardiac Surgical Procedures; | 1976 |
Is pretransplant antiarrhythmic drug therapy a risk factor?
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Cause of Death; Child; Femal | 1992 |
Postoperative acute respiratory distress syndrome. A complication of amiodarone associated with 100 percent oxygen ventilation.
Topics: Aged; Amiodarone; Humans; Male; Oxygen; Postoperative Complications; Respiration, Artificial; Respir | 1992 |
Successful catheter fulguration of the His bundle in a postoperative Mustard patient after unsuccessful fulguration of ectopic atrial foci.
Topics: Amiodarone; Bundle of His; Child; Electrocardiography; Electrocoagulation; Humans; Male; Pacemaker, | 1991 |
Amiodarone-related postoperative adult respiratory distress syndrome.
Topics: Aged; Amiodarone; Endocardium; Female; Humans; Incidence; Male; Middle Aged; Pacemaker, Artificial; | 1991 |
[Iodine-induced crisis in thyroid autonomy: a surgical emergency].
Topics: Amiodarone; Angiography; Emergencies; Humans; Iodine; Male; Middle Aged; Postoperative Complications | 1990 |
Amiodarone-induced complications after cardiac operation for obstructive hypertrophic cardiomyopathy.
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Cardiac Output, Low; Cardiomyopathy, Hypertrophic; Chemical | 1989 |
The automatic implantable cardioverter-defibrillator: efficacy, complications and survival in patients with malignant ventricular arrhythmias.
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Electric Countershock; Electrodes, Implan | 1988 |
Fatal postoperative amiodarone pulmonary toxicity.
Topics: Amiodarone; Humans; Lung; Postoperative Complications; Radiography, Thoracic; Respiratory Distress S | 1988 |
Life-threatening postoperative pulmonary complications in patients with previous amiodarone pulmonary toxicity undergoing cardiothoracic operations.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Female; Heart Diseases; Humans; Male; Middle Aged; Postopera | 1987 |
[Postoperative therapeutic effect of amiodarone on the conversion of chronic atrial fibrillation in rheumatic heart disease].
Topics: Adult; Amiodarone; Atrial Fibrillation; Chronic Disease; Female; Heart Valve Diseases; Heart Valve P | 1987 |
[3-week saturation with amiodarone before heart valve surgery. Study of postoperative rhythm disorders and plasma and myocardial levels of amiodarone].
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Drug Administration Schedule; Elec | 1987 |